{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "(function(on) {\n",
       "const e=$( \"<a>Setup failed</a>\" );\n",
       "const ns=\"js_jupyter_suppress_warnings\";\n",
       "var cssrules=$(\"#\"+ns);\n",
       "if(!cssrules.length) cssrules = $(\"<style id='\"+ns+\"' type='text/css'>div.output_stderr { } </style>\").appendTo(\"head\");\n",
       "e.click(function() {\n",
       "    var s='Showing';  \n",
       "    cssrules.empty()\n",
       "    if(on) {\n",
       "        s='';\n",
       "        cssrules.append(\"div.output_stderr, div[data-mime-type*='.stderr'] { display:none; }\");\n",
       "    }\n",
       "    e.text(s+'');\n",
       "    on=!on;\n",
       "}).click();\n",
       "$(element).append(e);\n",
       "})(true);\n"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "%%javascript\n",
    "(function(on) {\n",
    "const e=$( \"<a>Setup failed</a>\" );\n",
    "const ns=\"js_jupyter_suppress_warnings\";\n",
    "var cssrules=$(\"#\"+ns);\n",
    "if(!cssrules.length) cssrules = $(\"<style id='\"+ns+\"' type='text/css'>div.output_stderr { } </style>\").appendTo(\"head\");\n",
    "e.click(function() {\n",
    "    var s='Showing';  \n",
    "    cssrules.empty()\n",
    "    if(on) {\n",
    "        s='';\n",
    "        cssrules.append(\"div.output_stderr, div[data-mime-type*='.stderr'] { display:none; }\");\n",
    "    }\n",
    "    e.text(s+'');\n",
    "    on=!on;\n",
    "}).click();\n",
    "$(element).append(e);\n",
    "})(true);"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# COVID-19 Vaccine and Treatment Development Tracker\n",
    "\n",
    "Welcome to **covid-vaccine-tracker.com**. This website presents a summary of the data published by the **WHO** regarding the develipment of COVID-19 vaccines (https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1). Data for treatments for COVID-19 under development is derived from the **Milken Institute** vaccine and treatment spreadsheet (https://milkeninstitute.org/sites/default/files/2020-03/Covid19-Tracker-3-36-20-FINAL.pdf). No modifications have been made to the data. This has been done as an attempt to make this information more easily accessible to the public. The website is updated on a daily basis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## COVID-19 Vaccines in Development"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### COVID-19 Vaccine Platforms in Development"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "hide_input": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Got stderr: Mar 28, 2020 12:15:02 PM org.apache.pdfbox.pdmodel.font.PDCIDFontType2 <init>\n",
      "INFO: OpenType Layout tables used in font BCDGEE+Calibri-Light are not implemented in PDFBox and will be ignored\n",
      "Mar 28, 2020 12:15:06 PM org.apache.pdfbox.pdmodel.font.PDCIDFontType2 <init>\n",
      "INFO: OpenType Layout tables used in font BCDIEE+Calibri are not implemented in PDFBox and will be ignored\n",
      "\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "import pandas as pd\n",
    "\n",
    "import tabula\n",
    "\n",
    "import requests\n",
    "\n",
    "from ggplot import *\n",
    "\n",
    "import seaborn as sns\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "import numpy as np\n",
    "\n",
    "import matplotlib\n",
    "\n",
    "# Change figure sizes\n",
    "temp = plt.rcParams['figure.dpi'] = 100\n",
    "\n",
    "font = {'family' : 'normal',\n",
    "        'weight' : 'bold',\n",
    "        'size'   : 12}\n",
    "\n",
    "matplotlib.rc('font', **font)\n",
    "\n",
    "\n",
    "#url = 'https://milkeninstitute.org/sites/default/files/2020-03/Covid19-Tracker-3-36-20-FINAL.pdf'\n",
    "\n",
    "url = 'https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1'\n",
    "\n",
    "myfile = requests.get(url)\n",
    "open('COVID19-data.pdf', 'wb').write(myfile.content)\n",
    "\n",
    "#declare the path of your file\n",
    "file_path = \"COVID19-data.pdf\"\n",
    "#Convert your file\n",
    "df = tabula.read_pdf(file_path, pages='all', lattice=True,multiple_tables=False)\n",
    "#df = df[10]\n",
    "#df = df.drop(index=0)\n",
    "df = df[0]\n",
    "df = df.dropna(axis=0,thresh=5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "#%% Clean the data\n",
    "\n",
    "\n",
    "df.columns = ['platform', 'type_product', 'developer', 'covid', 'stage',\n",
    "              'other']\n",
    "\n",
    "a = df['platform'].values\n",
    "aa = df['stage'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(a)):\n",
    "    #aa[i] = aa[i].replace('\\r',' ')\n",
    "    b.append(a[i].replace('\\r',' '))\n",
    "    if b[i] == 'Platform':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['platform'] = b\n",
    "\n",
    "# Evaluate the different trial types\n",
    "stages = ['Pre-Clinical', 'Phase 1', 'Phase 2', 'Phase 3']\n",
    "\n",
    "c = df['stage'].values\n",
    "stage_list = []\n",
    "\n",
    "for i in range(len(c)):\n",
    "    stage = c[i]\n",
    "    for j in range(len(stages)):\n",
    "        if stages[j] in stage:\n",
    "            stage_list.append(stages[j])\n",
    "    if len(stage_list)<i+1:\n",
    "            stage_list.append(np.nan)\n",
    "    \n",
    "\n",
    "df['stage'] = stage_list\n",
    "\n",
    "\n",
    "# Change the typer of product\n",
    "d = df['type_product'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(d)):\n",
    "    b.append(d[i].replace('\\r',' '))\n",
    "    if b[i] == 'Type of candidate vaccine':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['type_product'] = b\n",
    "\n",
    "# Change the developer names\n",
    "d = df['developer'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(d)):\n",
    "    b.append(d[i].replace('\\r',' '))\n",
    "    if b[i] == 'Developer':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['developer'] = b\n",
    "\n",
    "# Change the other names\n",
    "d = df['other'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(d)):\n",
    "    if str(d[i]) == 'nan':\n",
    "        b.append(np.nan)\n",
    "    else:\n",
    "        b.append(d[i].replace('\\r',' '))\n",
    "    if b[i] == 'Same platform for non-Coronavirus candidates':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['other'] = b"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "findfont: Font family ['normal'] not found. Falling back to DejaVu Sans.\n",
      "findfont: Font family ['normal'] not found. Falling back to DejaVu Sans.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "#%% Plot\n",
    "#fig=plt.figure(figsize=(25, 10), dpi= 80, facecolor='w', edgecolor='k')\n",
    "chart = sns.catplot(x=\"platform\", kind=\"count\", palette=\"ch:.25\", data=df);\n",
    "t = plt.xlabel('Vaccine Platform')\n",
    "t = plt.ylabel('Count')\n",
    "t = chart.set_xticklabels(rotation=90)\n",
    "\n",
    "\n",
    "#chart2 = sns.catplot(x=\"stage\", kind=\"count\", palette=\"ch:.25\", data=df);\n",
    "#t = plt.xlabel('FDA Phase')\n",
    "#t = chart2.set_xticklabels(rotation=75)\n",
    "\n",
    "#%%\n",
    "#plt.figure()\n",
    "#plat_count = df['platform'].value_counts()\n",
    "#chart3 = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\")\n",
    "#plt.setp(chart3.get_xticklabels(), rotation=90)\n",
    "#plt.xlabel('Vaccine Platform')\n",
    "#plt.ylabel('Count')\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Vaccine Clincal Trial Phase"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "chart2 = sns.catplot(x=\"stage\", kind=\"count\", palette=\"ch:.25\", data=df);\n",
    "t = plt.xlabel('Trial Phase')\n",
    "t = plt.ylabel('Count')\n",
    "t = chart2.set_xticklabels(rotation=0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Vaccine Data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "I have filtered the WHO data and made it more accessible. If you would like a spreadsheet version of this data, please email me at: *covid.vaccine.tracker@gmail.com*"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop(columns='covid')\n",
    "df.columns = ['Vaccine Platform', 'Vaccine Specifics', 'Company \\n Developer', 'Trial Stage', 'Other Uses']\n",
    "df = df.dropna(axis=0,thresh=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "require.config({\n",
       "    paths: {\n",
       "        datatables: 'https://cdn.datatables.net/1.10.19/js/jquery.dataTables.min',\n",
       "    }\n",
       "});\n",
       "\n",
       "$('head').append('<link rel=\"stylesheet\" type=\"text/css\" \\\n",
       "                href = \"https://cdn.datatables.net/1.10.19/css/jquery.dataTables.min.css\" > ');\n",
       "\n",
       "$('head').append('<style> table td { text-overflow: ellipsis; overflow: hidden; } </style>');\n",
       "\n",
       "$('head').append(`<script>\n",
       "function eval_functions(map_or_text) {\n",
       "    if (typeof map_or_text === \"string\") {\n",
       "        if (map_or_text.startsWith(\"function\")) {\n",
       "            try {\n",
       "                // Note: parenthesis are required around the whole expression for eval to return a value!\n",
       "                // See https://stackoverflow.com/a/7399078/911298.\n",
       "                //\n",
       "                // eval(\"local_fun = \" + map_or_text) would fail because local_fun is not declared\n",
       "                // (using var, let or const would work, but it would only be declared in the local scope\n",
       "                // and therefore the value could not be retrieved).\n",
       "                const func = eval(\"(\" + map_or_text + \")\");\n",
       "                if (typeof func !== \"function\") {\n",
       "                    // Note: backquotes are super convenient!\n",
       "                    // https://developer.mozilla.org/en-US/docs/Web/JavaScript/Reference/Template_literals\n",
       "                    console.error(\"Evaluated expression \" + map_or_text + \" is not a function (type is \" + typeof func + \")\");\n",
       "                    return map_or_text;\n",
       "                }\n",
       "                // Return the function\n",
       "                return func;\n",
       "            } catch (e) {\n",
       "                // Make sure to print the error with a second argument to console.error().\n",
       "                console.error(\"itables was not able to parse \" + map_or_text, e);\n",
       "            }\n",
       "        }\n",
       "    } else if (typeof map_or_text === \"object\") {\n",
       "        if (map_or_text instanceof Array) {\n",
       "            // Note: \"var\" is now superseded by \"let\" and \"const\".\n",
       "            // https://medium.com/javascript-scene/javascript-es6-var-let-or-const-ba58b8dcde75\n",
       "            const result = [];\n",
       "            // Note: \"for of\" is the best way to iterate through an iterable.\n",
       "            // https://developer.mozilla.org/en-US/docs/Web/JavaScript/Reference/Statements/for...of\n",
       "            for (const item of map_or_text) {\n",
       "                result.push(eval_functions(item));\n",
       "            }\n",
       "            return result;\n",
       "\n",
       "            // Alternatively, more functional approach in one line:\n",
       "            // return map_or_text.map(eval_functions);\n",
       "        } else {\n",
       "            const result = {};\n",
       "            // Object.keys() is safer than \"for in\" because otherwise you might have keys\n",
       "            // that aren't defined in the object itself.\n",
       "            //\n",
       "            // See https://stackoverflow.com/a/684692/911298.\n",
       "            for (const item of Object.keys(map_or_text)) {\n",
       "                result[item] = eval_functions(map_or_text[item]);\n",
       "            }\n",
       "            return result;\n",
       "        }\n",
       "    }\n",
       "\n",
       "    return map_or_text;\n",
       "}\n",
       "</` + 'script>');"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div><table id=\"18fa34c3-7061-4513-9df8-8084d88b6a2b\" class=\"display\"><thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Vaccine Platform</th>\n",
       "      <th>Vaccine Specifics</th>\n",
       "      <th>Company \n",
       " Developer</th>\n",
       "      <th>Trial Stage</th>\n",
       "      <th>Other Uses</th>\n",
       "    </tr>\n",
       "  </thead></table>\n",
       "<script type=\"text/javascript\">\n",
       "require([\"datatables\"], function (datatables) {\n",
       "    $(document).ready(function () {        \n",
       "        var dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}], \"data\": [[0, \"Non- Replicating Viral Vector\", \"Adenovirus Type 5 Vector\", \"CanSino Biological Inc. and Beijing Institute of Biotechnology\", \"Phase 1\", \"Ebola\"], [1, \"RNA\", \"LNP- encapsulated mRNA\", \"Moderna/NIAID\", \"Phase 1\", \"multiple candidates\"], [6, \"DNA\", \"DNA plasmid vaccine Electroporation device\", \"Inovio Pharmaceuticals\", \"Pre-Clinical\", \"Lassa, Nipah HIV Filovirus HPV Cancer indications Zika Hepatitis B\"], [7, \"DNA\", \"DNA\", \"Takis/Applied DNA Sciences/Evvivax\", \"Pre-Clinical\", \"nan\"], [8, \"DNA\", \"DNA plasmid vaccine\", \"Zydus Cadila\", \"Pre-Clinical\", \"nan\"], [9, \"Inactivated\", \"Formaldehyde- inactivated + alum\", \"Sinovac\", \"Pre-Clinical\", \"SARS\"], [10, \"Live Attenuated Virus\", \"Deoptimized live attanuated vaccines\", \"Codagenix/Serum Institute of India\", \"Pre-Clinical\", \"HAV, InfA, ZIKV, FMD, SIV, RSV, DENV\"], [11, \"Non- Replicating Viral Vector\", \"MVA encoded VLP\", \"GeoVax/BravoVax\", \"Pre-Clinical\", \"LASV, EBOV, MARV, HIV\"], [12, \"Non- Replicating Viral Vector\", \"Ad26 (alone or with MVA boost)\", \"Janssen Pharmaceutical Companies\", \"Pre-Clinical\", \"Ebola, HIV, RSV\"], [13, \"Non- Replicating Viral Vector\", \"ChAdOx1\", \"University of Oxford\", \"Pre-Clinical\", \"influenza, TB, Chikungunya, Zika, MenB, plague\"], [14, \"Non- Replicating Viral Vector\", \"adenovirus- based NasoVAX expressing SARS2-CoV spike protein\", \"Altimmune\", \"Pre-Clinical\", \"influenza\"], [15, \"Non- Replicating Viral Vector\", \"Ad5 S (GREVAXTM platform)\", \"Greffex\", \"Pre-Clinical\", \"MERS\"], [16, \"Non- Replicating Viral Vector\", \"Oral Vaccine platform\", \"Vaxart\", \"Pre-Clinical\", \"InfA, CHIKV, LASV, NORV; EBOV, RVF, HBV, VEE\"], [17, \"Protein Subunit\", \"Drosophila S2 insect cell expression system VLPs\", \"ExpreS2ion\", \"Pre-Clinical\", \"nan\"], [18, \"Protein Subunit\", \"S protein\", \"WRAIR/USAMRIID\", \"Pre-Clinical\", \"nan\"], [19, \"Protein Subunit\", \"S-Trimer\", \"Clover Biopharmaceuticals Inc./GSK\", \"Pre-Clinical\", \"HIV, REV Influenza\"], [20, \"Protein Subunit\", \"Peptide\", \"Vaxil Bio\", \"Pre-Clinical\", \"nan\"], [21, \"Protein Subunit\", \"S protein\", \"AJ Vaccines\", \"Pre-Clinical\", \"nan\"], [22, \"Protein Subunit\", \"Ii-Key peptide\", \"Generex/EpiVax\", \"Pre-Clinical\", \"Influenza, HIV, SARS- CoV\"], [23, \"Protein Subunit\", \"S protein\", \"EpiVax/Univ. of Georgia\", \"Pre-Clinical\", \"H7N9\"], [24, \"Protein Subunit\", \"S protein (baculovirus production)\", \"Sanofi Pasteur\", \"Pre-Clinical\", \"Influenza, SARS-CoV\"], [25, \"Protein Subunit\", \"Full length S trimers/ nanoparticle + Matrix M\", \"Novavax\", \"Pre-Clinical\", \"RSV; CCHF, HPV, VZV, EBOV\"], [26, \"Protein Subunit\", \"gp-96 backbone\", \"Heat Biologics/Univ. Of Miami\", \"Pre-Clinical\", \"NSCLC, HIV, malaria, Zika\"], [27, \"Protein Subunit\", \"Molecular clamp stabilized Spike protein\", \"University of Queensland/GSK\", \"Pre-Clinical\", \"Nipah, influenza, Ebola, Lassa\"], [28, \"Protein Subunit\", \"S1 or RBD protein\", \"Baylor College of Medicine\", \"Pre-Clinical\", \"SARS\"], [29, \"Protein Subunit\", \"Subunit protein, plant produced\", \"iBio/CC-Pharming\", \"Pre-Clinical\", \"nan\"], [30, \"Protein Subunit\", \"Subunit\", \"VIDO-InterVac, University of Saskatchewan\", \"Pre-Clinical\", \"nan\"], [31, \"Protein Subunit\", \"Adjuvanted microsphere peptide\", \"University of Saskatchewan\", \"Pre-Clinical\", \"nan\"], [32, \"Replicating Viral Vector\", \"Measles Vector\", \"Zydus Cadila\", \"Pre-Clinical\", \"nan\"], [33, \"Replicating Viral Vector\", \"Measles Vector\", \"Institute Pasteur/Themis/Univ. of Pittsburg Center for Vaccine Research\", \"Pre-Clinical\", \"West nile, chik, Ebola, Lassa, Zika\"], [34, \"Replicating Viral Vector\", \"Horsepox vector expressing S protein\", \"Tonix Pharma/Southern Research\", \"Pre-Clinical\", \"Smallpox, monkeypox\"], [35, \"RNA\", \"LNP- encapsulated mRNA  cocktail encoding VLP\", \"Fudan University/ Shanghai JiaoTong University/RNACure Biopharma\", \"Pre-Clinical\", \"nan\"], [36, \"RNA\", \"LNP- encapsulated mRNA encoding RBD\", \"Fudan University/ Shanghai JiaoTong University/RNACure Biopharma\", \"Pre-Clinical\", \"nan\"], [37, \"RNA\", \"mRNA\", \"China CDC/Tongji University/Stermina\", \"Pre-Clinical\", \"nan\"], [38, \"RNA\", \"mRNA\", \"Arcturus/Duke-NUS\", \"Pre-Clinical\", \"multiple candidates\"], [39, \"RNA\", \"mRNA\", \"BioNTech/Fosun Pharma/Pfizer\", \"Pre-Clinical\", \"nan\"], [40, \"RNA\", \"saRNA\", \"Imperial College London\", \"Pre-Clinical\", \"EBOV; LASV, MARV, Inf (H7N9), RABV\"], [41, \"RNA\", \"mRNA\", \"Curevac\", \"Pre-Clinical\", \"RABV, LASV, YFV; MERS, InfA, ZIKV, DengV, NIPV\"], [42, \"VLP\", \"Plant-derived VLP\", \"Medicago Inc.\", \"Pre-Clinical\", \"Flu, Rotavirus, Norovirus, West Nile virus, Cancer\"], [43, \"Unknown\", \"Unknown\", \"University of Hong Kong\", \"Pre-Clinical\", \"nan\"], [44, \"Unknown\", \"Unknown\", \"ImmunoPrecise\", \"Pre-Clinical\", \"nan\"], [45, \"Unknown\", \"Unknown\", \"MIGAL Galilee Research Institute\", \"Pre-Clinical\", \"nan\"], [46, \"Unknown\", \"Unknown\", \"Doherty Institute\", \"Pre-Clinical\", \"nan\"], [47, \"Unknown\", \"Unknown\", \"Tulane University\", \"Pre-Clinical\", \"nan\"]]};\n",
       "        dt_args = eval_functions(dt_args);\n",
       "        table = $('#18fa34c3-7061-4513-9df8-8084d88b6a2b').DataTable(dt_args);\n",
       "    });\n",
       "})\n",
       "</script>\n",
       "</div>\n"
      ],
      "text/plain": [
       "                 Vaccine Platform  \\\n",
       "0   Non- Replicating Viral Vector   \n",
       "1                             RNA   \n",
       "6                             DNA   \n",
       "7                             DNA   \n",
       "8                             DNA   \n",
       "9                     Inactivated   \n",
       "10          Live Attenuated Virus   \n",
       "11  Non- Replicating Viral Vector   \n",
       "12  Non- Replicating Viral Vector   \n",
       "13  Non- Replicating Viral Vector   \n",
       "14  Non- Replicating Viral Vector   \n",
       "15  Non- Replicating Viral Vector   \n",
       "16  Non- Replicating Viral Vector   \n",
       "17                Protein Subunit   \n",
       "18                Protein Subunit   \n",
       "19                Protein Subunit   \n",
       "20                Protein Subunit   \n",
       "21                Protein Subunit   \n",
       "22                Protein Subunit   \n",
       "23                Protein Subunit   \n",
       "24                Protein Subunit   \n",
       "25                Protein Subunit   \n",
       "26                Protein Subunit   \n",
       "27                Protein Subunit   \n",
       "28                Protein Subunit   \n",
       "29                Protein Subunit   \n",
       "30                Protein Subunit   \n",
       "31                Protein Subunit   \n",
       "32       Replicating Viral Vector   \n",
       "33       Replicating Viral Vector   \n",
       "34       Replicating Viral Vector   \n",
       "35                            RNA   \n",
       "36                            RNA   \n",
       "37                            RNA   \n",
       "38                            RNA   \n",
       "39                            RNA   \n",
       "40                            RNA   \n",
       "41                            RNA   \n",
       "42                            VLP   \n",
       "43                        Unknown   \n",
       "44                        Unknown   \n",
       "45                        Unknown   \n",
       "46                        Unknown   \n",
       "47                        Unknown   \n",
       "\n",
       "                                    Vaccine Specifics  \\\n",
       "0                            Adenovirus Type 5 Vector   \n",
       "1                              LNP- encapsulated mRNA   \n",
       "6          DNA plasmid vaccine Electroporation device   \n",
       "7                                                 DNA   \n",
       "8                                 DNA plasmid vaccine   \n",
       "9                    Formaldehyde- inactivated + alum   \n",
       "10               Deoptimized live attanuated vaccines   \n",
       "11                                    MVA encoded VLP   \n",
       "12                     Ad26 (alone or with MVA boost)   \n",
       "13                                            ChAdOx1   \n",
       "14  adenovirus- based NasoVAX expressing SARS2-CoV...   \n",
       "15                          Ad5 S (GREVAXTM platform)   \n",
       "16                              Oral Vaccine platform   \n",
       "17   Drosophila S2 insect cell expression system VLPs   \n",
       "18                                          S protein   \n",
       "19                                           S-Trimer   \n",
       "20                                            Peptide   \n",
       "21                                          S protein   \n",
       "22                                     Ii-Key peptide   \n",
       "23                                          S protein   \n",
       "24                 S protein (baculovirus production)   \n",
       "25     Full length S trimers/ nanoparticle + Matrix M   \n",
       "26                                     gp-96 backbone   \n",
       "27           Molecular clamp stabilized Spike protein   \n",
       "28                                  S1 or RBD protein   \n",
       "29                    Subunit protein, plant produced   \n",
       "30                                            Subunit   \n",
       "31                     Adjuvanted microsphere peptide   \n",
       "32                                     Measles Vector   \n",
       "33                                     Measles Vector   \n",
       "34               Horsepox vector expressing S protein   \n",
       "35      LNP- encapsulated mRNA  cocktail encoding VLP   \n",
       "36                LNP- encapsulated mRNA encoding RBD   \n",
       "37                                               mRNA   \n",
       "38                                               mRNA   \n",
       "39                                               mRNA   \n",
       "40                                              saRNA   \n",
       "41                                               mRNA   \n",
       "42                                  Plant-derived VLP   \n",
       "43                                            Unknown   \n",
       "44                                            Unknown   \n",
       "45                                            Unknown   \n",
       "46                                            Unknown   \n",
       "47                                            Unknown   \n",
       "\n",
       "                                 Company \\n Developer   Trial Stage  \\\n",
       "0   CanSino Biological Inc. and Beijing Institute ...       Phase 1   \n",
       "1                                       Moderna/NIAID       Phase 1   \n",
       "6                              Inovio Pharmaceuticals  Pre-Clinical   \n",
       "7                  Takis/Applied DNA Sciences/Evvivax  Pre-Clinical   \n",
       "8                                        Zydus Cadila  Pre-Clinical   \n",
       "9                                             Sinovac  Pre-Clinical   \n",
       "10                 Codagenix/Serum Institute of India  Pre-Clinical   \n",
       "11                                    GeoVax/BravoVax  Pre-Clinical   \n",
       "12                   Janssen Pharmaceutical Companies  Pre-Clinical   \n",
       "13                               University of Oxford  Pre-Clinical   \n",
       "14                                          Altimmune  Pre-Clinical   \n",
       "15                                            Greffex  Pre-Clinical   \n",
       "16                                             Vaxart  Pre-Clinical   \n",
       "17                                         ExpreS2ion  Pre-Clinical   \n",
       "18                                     WRAIR/USAMRIID  Pre-Clinical   \n",
       "19                 Clover Biopharmaceuticals Inc./GSK  Pre-Clinical   \n",
       "20                                          Vaxil Bio  Pre-Clinical   \n",
       "21                                        AJ Vaccines  Pre-Clinical   \n",
       "22                                     Generex/EpiVax  Pre-Clinical   \n",
       "23                            EpiVax/Univ. of Georgia  Pre-Clinical   \n",
       "24                                     Sanofi Pasteur  Pre-Clinical   \n",
       "25                                            Novavax  Pre-Clinical   \n",
       "26                      Heat Biologics/Univ. Of Miami  Pre-Clinical   \n",
       "27                       University of Queensland/GSK  Pre-Clinical   \n",
       "28                         Baylor College of Medicine  Pre-Clinical   \n",
       "29                                   iBio/CC-Pharming  Pre-Clinical   \n",
       "30          VIDO-InterVac, University of Saskatchewan  Pre-Clinical   \n",
       "31                         University of Saskatchewan  Pre-Clinical   \n",
       "32                                       Zydus Cadila  Pre-Clinical   \n",
       "33  Institute Pasteur/Themis/Univ. of Pittsburg Ce...  Pre-Clinical   \n",
       "34                     Tonix Pharma/Southern Research  Pre-Clinical   \n",
       "35  Fudan University/ Shanghai JiaoTong University...  Pre-Clinical   \n",
       "36  Fudan University/ Shanghai JiaoTong University...  Pre-Clinical   \n",
       "37               China CDC/Tongji University/Stermina  Pre-Clinical   \n",
       "38                                  Arcturus/Duke-NUS  Pre-Clinical   \n",
       "39                       BioNTech/Fosun Pharma/Pfizer  Pre-Clinical   \n",
       "40                            Imperial College London  Pre-Clinical   \n",
       "41                                            Curevac  Pre-Clinical   \n",
       "42                                      Medicago Inc.  Pre-Clinical   \n",
       "43                            University of Hong Kong  Pre-Clinical   \n",
       "44                                      ImmunoPrecise  Pre-Clinical   \n",
       "45                   MIGAL Galilee Research Institute  Pre-Clinical   \n",
       "46                                  Doherty Institute  Pre-Clinical   \n",
       "47                                  Tulane University  Pre-Clinical   \n",
       "\n",
       "                                           Other Uses  \n",
       "0                                               Ebola  \n",
       "1                                 multiple candidates  \n",
       "6   Lassa, Nipah HIV Filovirus HPV Cancer indicati...  \n",
       "7                                                 NaN  \n",
       "8                                                 NaN  \n",
       "9                                                SARS  \n",
       "10               HAV, InfA, ZIKV, FMD, SIV, RSV, DENV  \n",
       "11                              LASV, EBOV, MARV, HIV  \n",
       "12                                    Ebola, HIV, RSV  \n",
       "13     influenza, TB, Chikungunya, Zika, MenB, plague  \n",
       "14                                          influenza  \n",
       "15                                               MERS  \n",
       "16       InfA, CHIKV, LASV, NORV; EBOV, RVF, HBV, VEE  \n",
       "17                                                NaN  \n",
       "18                                                NaN  \n",
       "19                                 HIV, REV Influenza  \n",
       "20                                                NaN  \n",
       "21                                                NaN  \n",
       "22                          Influenza, HIV, SARS- CoV  \n",
       "23                                               H7N9  \n",
       "24                                Influenza, SARS-CoV  \n",
       "25                          RSV; CCHF, HPV, VZV, EBOV  \n",
       "26                          NSCLC, HIV, malaria, Zika  \n",
       "27                     Nipah, influenza, Ebola, Lassa  \n",
       "28                                               SARS  \n",
       "29                                                NaN  \n",
       "30                                                NaN  \n",
       "31                                                NaN  \n",
       "32                                                NaN  \n",
       "33                West nile, chik, Ebola, Lassa, Zika  \n",
       "34                                Smallpox, monkeypox  \n",
       "35                                                NaN  \n",
       "36                                                NaN  \n",
       "37                                                NaN  \n",
       "38                                multiple candidates  \n",
       "39                                                NaN  \n",
       "40                 EBOV; LASV, MARV, Inf (H7N9), RABV  \n",
       "41     RABV, LASV, YFV; MERS, InfA, ZIKV, DengV, NIPV  \n",
       "42  Flu, Rotavirus, Norovirus, West Nile virus, Ca...  \n",
       "43                                                NaN  \n",
       "44                                                NaN  \n",
       "45                                                NaN  \n",
       "46                                                NaN  \n",
       "47                                                NaN  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Show an interactive dataframe table\n",
    "import itables.interactive\n",
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## COVID-19 Treatment Options in Development"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# load the data\n",
    "url = 'https://milkeninstitute.org/sites/default/files/2020-03/Covid19-Tracker-3-36-20-FINAL.pdf'\n",
    "\n",
    "#url = 'https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1'\n",
    "\n",
    "myfile = requests.get(url)\n",
    "open('COVID19-data2.pdf', 'wb').write(myfile.content)\n",
    "\n",
    "#declare the path of your file\n",
    "file_path = \"COVID19-data2.pdf\"\n",
    "#Convert your file\n",
    "df = tabula.read_pdf(file_path, pages='all', lattice=True,multiple_tables=True)\n",
    "#df = df[10]\n",
    "#df = df.drop(index=0)\n",
    "#df = df[0]\n",
    "#df = df.dropna(axis=0,thresh=5)\n",
    "\n",
    "\n",
    "\n",
    "for i in range(len(df)):\n",
    "    temp_df = df[i]\n",
    "    if temp_df.shape[1] == 9:\n",
    "        if 'df_all' in locals():\n",
    "            df_all = df_all.append(temp_df)\n",
    "        else:\n",
    "            df_all = temp_df\n",
    "        \n",
    "df_all = df_all.dropna(axis=0, thresh=5)\n",
    "df_all = df_all.dropna(axis=1, how='all')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# prepare the data\n",
    "#%% Remove the control characters\n",
    "cols = list(df_all.columns)\n",
    "for i in range(len(cols)):\n",
    "    list_a = df_all[cols[i]].values\n",
    "    for j in range(len(list_a)):\n",
    "        if isinstance(list_a[j], str) and ('\\r' in list_a[j]):\n",
    "            list_a[j] = list_a[j].replace('\\r',' ')\n",
    "        if isinstance(list_a[j], str) and ('*' in list_a[j]):\n",
    "            list_a[j] = list_a[j].replace('*','')\n",
    "        \n",
    "    df_all[cols[i]] = list_a\n",
    "\n",
    "for i in range(len(cols)):\n",
    "    if isinstance(cols[i], str) and ('\\r' in cols[i]):\n",
    "        cols[i] = cols[i].replace('\\r',' ')\n",
    "    if isinstance(cols[i], str) and ('*' in cols[i]):\n",
    "        cols[i] = cols[i].replace('*','')\n",
    "    \n",
    "df_all.columns = cols"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### COVID-19 Treatment Options (Top 5 Pursued Approaches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plat_count = df_all['Type of Product - Treatment'].value_counts()\n",
    "n_plot = 5\n",
    "chart = sns.barplot(plat_count[:n_plot].index, plat_count[:n_plot].values, alpha=0.8,palette=\"ch:.25\")\n",
    "plt.setp(chart.get_xticklabels(), rotation=90)\n",
    "plt.xlabel('Top '+ str(n_plot)+' Treatment Approaches Being Pursued')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Treatment Trial Phase"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAh4AAAHsCAYAAACdcaTFAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAPYQAAD2EBqD+naQAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAgAElEQVR4nOzdebxtc/3H8df7ji7uvaZruGYRIQplqGTIVCqlJBLxU1E0SaSBBheZpYkQ5Vd+pgoR3cwkKUmiTJln13gn9/P74/PdzrrbOeeec+45a599zvv5eOzH2Xuttff9HvtY67O+38/381VEYGZmZlaHEa1ugJmZmQ0fDjzMzMysNg48zMzMrDYOPMzMzKw2DjzMzMysNg48zMzMrDYOPMzMzKw2wzrwUJogSa1ui5mZ2XAwqtUNaLHxwLRp06a1uh1mZmbtqNc37sO6x8PMzMzqNegCD0mXSorKY42m/etKOlfS45JmSLpP0omSJrWqzWZmZtYzg2qoRdIngG262b8FcDGwQGXzisB+wHskbRIRjw1sK83MzKyvBk2Ph6TJwLHAHGB6J/tHA2eQQcccYFdgceC4csgqwDF1tNXMzMz6ZtAEHsCPgEXI4KOzXoutgeXL86sj4uyIeBr4Kh2Byk6SJg54S83MzKxPBkXgIWlX4L3AXcA3ujhsw8rz2xpPImI68O/ycjSwXjf/ztgyfXaCpAnkrBYzMzOrScsDD0lLASeQwyd7RsTLXRy6VOX5s037pnVxXLODy7GNx4O9a62ZmZnNj5YHHsDJZK7GiRFxXQ/f0zxvuPo6unnfFGBi5bFcTxtpZmZm86+ls1okbQDsSPZgXFBeA4ypHLaWpBHMnfexSNNHVfM6upzVEhEzgBmVf78vzTYzM7M+avV02oXLz0WAq7o45lzgVjKJtGHtxhNJCwCrlpezgFv6uY1mZmbWTwbDUEtPXQ48UJ5vKumjkhYFDqejrsc5EfFcS1pnZmZm86SI7lIiWkPSfWRhMIA3RMS/yvbOCog13Ats3JsCYmVmy7Rp06YxYcKE+Wu0mZnZ8DO012qJiKnARsB5wJPk0Mr9wEnAhq5aamZmNrgNyh6PuvS2x+PRe2+b5zHWv5Ze+Y2tboKZmXVtaPd4mJmZWXtz4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtWl54CFpPUnnS/qPpGmSZkt6StJVkvaWpMqxZ0iKbh4rte43MTMzs3kZ1eoGAGsCH2jathiwaXmsAXyp7kaZmZlZ/2t5jwdwN/BpYDVgHLAc8LPK/r06ec/9EaFOHvcNfHPNzMysr1re4xERNwA3VDY9JOlYYPfyemb9rTIzM7OBMBh6PF4laYSk5YEvVjYf28mhkyU9KWmWpIck/VzS6j34/LGSJjQewPj+aruZmZnNW8t7PBok3QhsWNk0GzgwIo7r5PDRwOLl+WRgV+D9kt4ZEbd0888cDHyzP9pr7e/Pv/pFq5sw7LzlI7u2uglm1mKDqsejySjgWEkHVrZNBXYCViDzQdYHGoHGwsAR8/jMKcDEymO5/mywmZmZdW/QBB4RsREZbCzH3L0S35E0qRxzZkT8X0Q8EBHTS+/G/pVjN5nHvzEjIp5rPIDn+/nXMDMzs24MmsADICJeiYiHIuJbwLSyeTSwiqSetHXOwLXOzMzM5lfLAw9Jx0vaUdJKksZIWlrSIeRQCMArwL3ACpJukrSbpMklUXQ94ITKx11Vd/vNzMys5wZDcukOwOe62T8lIh4vVUnfApzZxXFPAAf0b9PMzMysPw2GwONHwDbA6nTMVHkMuBn4aURcXLY9SgYo25DVTpcCBNwP/A44MiIerbHdZmZm1kstDzwi4gjmPRuFiJgOnFgeZmZm1oZanuNhZmZmw4cDDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrTcsDD0nrSTpf0n8kTZM0W9JTkq6StLckNR2/rqRzJT0uaYak+ySdKGlSq34HMzMz65lRrW4AsCbwgaZtiwGblscawJcAJG0BXAwsUDl2RWA/4D2SNomIxwa8xWZmZtYnLe/xAO4GPg2sBowDlgN+Vtm/F4Ck0cAZZNAxB9gVWBw4rhy3CnBMLS02MzOzPml54BERN0TEjyPiPxExPSIeAo6tHDKz/NwaWL48vzoizo6Ip4GvAtPL9p0kTayn5WZmZtZbLQ88qiSNkLQ88MXK5kYQsmFl222NJxExHfh3eTkaWK+bzx8raULjAYzvn5abmZlZTwyGHA8AJN3I3MHFbODAiGgMpSxV2fds09unVZ4vRdcOBr7Z50aamZnZfBlUPR5NRgHHSjqwk33q5nV085lTgImVx3Lz1UIzMzPrlUETeETERmSwsRxz90p8p0yVrc5WWaTp7dW8ji5ntUTEjIh4rvEAnp/PZpuZmVkvDJrAAyAiXomIhyLiW3QMn4wmZ6zcWDl07cYTSQsAq5aXs4Bb6mirmZmZ9V7LAw9Jx0vaUdJKksZIWlrSIXT0YrwC3AtcDjxQtm0q6aOSFgUOp6OuxzmlJ8PMzMwGocGQXLoD8Llu9k+JiMcBJO1BRwGxs5uOu5dSaMzMzMwGp5b3eAA/Aq4EHiFrdswkezYuALaPiK83DoyIqcBGwHnAk+TQyv3AScCGrlpqZmY2uLW8xyMijgCO6MXxtwIfGrgWmZmZ2UAZDD0eZmZmNkw48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2jjwMDMzs9o48DAzM7PaOPAwMzOz2rQ88JD0dkk/kHSLpMckzZB0n6TfSHpb07GHSopuHpu16NcwMzOzHhjV6gYAHwM+1bRtxfJ4r6RPRsQp9TfLzMzM+lvLezyAOcC5wNbAwsBy5XXDFEkjm98UEerkcWUtLTYzM7M+GQw9HgdFxHOV1y9K2hf4UHm9ODAJeLT2lpmZmVm/anmPR1PQ0bBg5flLwFPNB0h6RNIsSY9LukDSW+f1b0kaK2lC4wGM73vLzczMrLdaHng0kyTg6MqmH0fErE4OXZrssZkE7ABcJ+nd8/j4g4FplceD899iMzMz66lBFXhIGgOcRccwy1QyWGi4BdgDWAUYB7wB+H3ZNwo4fh7/xBRgYuWxXH+028zMzHpmMOR4AFCGPi4AtiibfgPsHBEzGsdExG+a3vYvSXvS0XOxmqQlIuLJzv6N8lmvfl52rpiZmVldBkWPh6RlgWvoCDpOBj4YES83Hfea2S1ANL2e0/8tNDMzs/7Q8sBD0trAjcA6ZBBxYER8NiJe6eTwf0jaR9JKksZIWgM4vbo/Ip6uodlmZmbWBy0PPIAD6Mi1EHBUNxVJ1wB+ANxLDpncQdb/gJz9sk99zTYzM7PeGgyBR2/sDZwP3A28AMwE7gFOBd4UEde2sG1mZmY2Dy1PLo2IPciZKj059lQyyDAzM7M21G49HmZmZtbGHHiYmZlZbRx4mJmZWW0ceJiZmVlt+hR4SHqlq0XZJK0vqbMaHGZmZjbM9bXHo7ta4yN4bTVRMzMzs/kaaukquFifXPnVzMzMbC49ruMh6XPA58rLAC6UNKPpsHHAksC5/dM8MzMzG0p6U0DsceD28nwlsmLos03HzABuA06Y75aZmZnZkNPjwCMi/hf4XwBJfwT2iYh/DVTDzMzMbOjpU8n0iNi8vxtiZmZmQ1+f12qRJOAtwIpkbsdcIuLM+WiXmZmZDUF9CjwkvR74DbAanU+tDcCBh5mZmc2lrz0eJwMLAB8B/k4mlZqZmZl1q6+Bx1uBvSPC02bNzMysx/paQOwF4Ln+bIiZmZkNfX0NPE4HdunPhpiZmdnQ19ehln8AH5X0G+C3wFPNB0TE+fPTMDMzMxt6+hp4nF1+rgxs38n+AEb28bPNzMxsiOpr4OECYmZmZtZrfa1celV/N8TMzMyGvr4ml5qZmZn1Wl8rl06dxyEREVv25bPNzMxs6OprjscIMoG0aglgdeBx4K75aZSZmZkNTX3N8diss+1lDZdfA4f19LMkvZ2sCbIRsCywCPAIWYr9yIi4run4lYFvAFsDk4AngN8Dh0XEfb38VczMzKxG/ZrjERF3Ad8DjurF2z4G7AO8GVgSGEOuePte4FpJezcOlLQ2cDOwBzAZGF1+7gH8WdIb5vuXMDMzswEzEMml9wFr9+L4OcC5ZA/GwsBy5XXDFEmNmiCnAIuV5weU5weU10uU/WZmZjZIDUTgsSPwcC+OPygiPhwRl0fEixHxELBvZf/iwCRJa5HDMQD3RcQxEfFMRBxDBjsAb3Ovh5mZ2eDV11ktp3WyeSywDrAmcGBPPysiOltsbsHK85fIkuzvrmy7ren424CVyvONgDs6+7ckjS3tbBjf03aamZnZ/OvrrJYteO2slulkz8OUiDj7Ne/oIUkCjq5s+nFEzJK0VGXbs01vm1Z5vhRdOxj4Zl/bZmZmZvOnr7NaVurndgAgaQxwGvChsmkqGSy85tBuXjcHRFVTgGMrr8cDD/aymWZmZtZHfe3x6HeSJgAXkL0pAL8Bdo6IGeX1Y5XDF2l6+8TK88foQvmsxueRnStmZmZWlz4HHpIWA74AbEkmgD4JXAEcHxHP9PKzlgUuIXNEAE4GPhcRr1QOu7HyvHnWTPX1n3rzb5uZmVl9+jSrpQQKtwCHkL0N/yV7Ib4O3CJpci8+a20yqFiHHCY5MCI+2xR0EBH/pCP4WEnSlyQtIulLdCSWXhcRnSaWmpmZWev1dTrt4cA4YMOIWCsitoqItYANy/bDe/FZB5C1OyBzNY6SFE2Pzcr+vYGny/OjgWfoSER9quw3MzOzQaqvgce2wNci4s/VjeX1N4Dt5rdhnYmIfwAbAD8jy6rPKj/PADZwb4eZmdng1tccj4l0FO1qdi9zJ3t2KyL2IEue9/T4e3tzvJmZmQ0efe3xuBd4Txf7tiv7zczMzObS1x6P04EjJI2gY9hjGXLBt/2Ag/qneWZmZjaU9DXw+B7wOuCzwGcq2wX8JCKO7vRdZmZmNqz1tXJpAJ+SdCywOVnH4ylgakTc1Y/tMzMzsyGkx4GHpEWBU4HTI+IigIi4E7izcsz2kqYAn4yIp/q7sWZmZtbeepNc+j/AusCl3RxzKfBG5h5+MTMzMwN6F3jsDJwSEbO7OqDsOwV43/w2zMzMzIae3gQerwdu7sFxt5RjzczMzObSm8BjFFkpdF5mAaP71hwzMzMbynoTeDwCrNmD49YCHu1bc8zMzGwo603gcRWwr6QuezPKvn2AP85vw8zMzGzo6U3gcRywBnBBZ8vel20XAquXY83MzMzm0uM6HhHxd0mfAX4A3CvpL3SsybIysD4ZyOwTEbf1e0vNzMys7fWqcmlEnCLpH8BXyYqlG5VdL5E1PKZExI3920QzMzMbKnpdMj0ibgDeWxaIW6JsfjIi5vRry8zMzGzI6esicZRA4/F+bIuZmZkNcb1JLjUzMzObLw48zMzMrDYOPMzMzKw2DjzMzMysNg48zMzMrDYOPMzMzKw2DjzMzMysNoMi8JA0RtKRkv4o6TlJUR5XdnLsGZX9nT1Wqv0XMDMzsx7pcwGxfrYgcGCrG2FmZmYDa7AEHrOAHwJ/BhYGTuzBe+6PiJUGslFmZmbWvwZF4BERLwL7AkjatsXNMTMzswEyKHI8+miypCclzZL0kKSfS1q9uzdIGitpQuMBjK+prWZmZkZ7Bx6jgcXJXpvJwK7AzZLW6+Y9BwPTKo8HB7qRZmZm1qEdA4+pwE7ACsA4YH3glrJvYeCIbt47BZhYeSw3cM00MzOzZoMix6M3IuLMpk23SNofuLa83qSb984AZjReS+r/BpqZmVmX2qrHQ1JP2jtnwBtiZmZmfTJoAg9JS0haAphQ2Ty6sV3SgsAKkm6StJukySVZdD3ghMp7rqq14WZmZtZjg2mo5YlOtm1S2X4YcAbwFqB5uKX6GQf0e8vMzMysXwyaHo8eehT4HHAJcB/wMjAduBM4HlgnIu5sWevMzMysW4OmxyMieprpeSI9q2xqZmZmg0y79XiYmZlZG3PgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1ceBhZmZmtXHgYWZmZrVx4GFmZma1GRSBh6Qxko6U9EdJz0mK8riyi+PXlXSupMclzZB0n6QTJU2quelmZmbWC6Na3YBiQeDAnhwoaQvgYmCByuYVgf2A90jaJCIe6/8mmpmZ2fwaFD0ewCzgh8CewP5dHSRpNHAGGXTMAXYFFgeOK4esAhwzkA01MzOzvhsUgUdEvBgR+0bE6cC/uzl0a2D58vzqiDg7Ip4GvgpML9t3kjRxAJtrZmZmfTQoAo9e2LDy/LbGk4iYTkfAMhpYr7M3SxoraULjAYwfsJaamZnZa7Rb4LFU5fmzTfumdXFc1cHluMbjwf5rmpmZmc1LuwUeVermdXTxninAxMpjuQFol5mZmXVhsMxq6anqbJVFmvZN7OK4V0XEDGBG47XUHLuYmZnZQGq3Ho8bK8/XbjyRtACwank5C7ilzkaZmZlZzwyawEPSEpKWACZUNo9ubJe0IHA58EDZt6mkj0paFDicjroe50TEc/W13MzMzHpqMA21PNHJtk0q2w+LiEMl7UFHAbGzm46/F/jSgLXQzMzM5sug6fHoqYiYCmwEnAc8SQ6t3A+cBGzoqqVmZmaD16Dp8YiIHmd6RsStwIcGsDlmZmY2ANqux8PMzMzalwMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6uNAw8zMzOrjQMPMzMzq40DDzMzM6tN2wUekjaTFN08Dm11G83MzKxzbRd4mJmZWfsa1eoGzKfNI+LKVjfCzMzMesY9HmZmZlabdg88zpE0U9I0SVdL+mh3B0saK2lC4wGMr6mdZmZmRvsHHpOA0cAE4B3A2ZIO7+b4g4FplceDA95CMzMze1U7Bh6PAQcAawMLAcsAR1f2Hyhp+S7eOwWYWHksN4DtNDMzsyZtl1waEXcAd1Q2vQR8WdIOwKrASGBD4IFO3jsDmNF4LWlgG2tmZmZzabseD0kju9gVledz6miLmZmZ9U7b9XiQCaW3A+cCdwKLAl8CViv7ZwE3tKhtZmZm1o12DDwWB75eHp05KCIeqbE9ZmZm1kPtGHh8B/g3sDEwmZwS+xRwI3BSRPyhhW0zMzOzbrRd4BERVwBXtLodZmZm1nttl1xqZmZm7cuBh5mZmdXGgYeZmZnVxoGHmZmZ1caBh5mZmdXGgYeZmZnVxoGHmZmZ1caBh5mZmdXGgYeZmZnVxoGHmZmZ1caBh5mZmdXGgYeZmZnVxoGHmZmZ1caBh5mZmdXGgYeZmZnVxoGHmZmZ1caBh5mZmdXGgYeZmZnVxoGHmZmZ1caBh5mZmdXGgYeZmZnVxoGHmZmZ1WZUqxtgZtZffvqVw1vdhGFnryO/OmCfvdv2uw3YZ1vnzrrorAH/N9zjYWZmZrVpy8BD0sKSviPpTknTJT0t6RJJ72h128zMzKxrbTfUImkh4GrgzZXNY4HtgG0k7RoRv2xJ48zMzKxb7djj8XU6go5zgCWBdwEvkb/PjyUt1qK2mZmZWTfaKvCQJGDPyqYDI+KJiPgDGYQATAA+UnvjzMzMbJ7abahlZWBSef58RNxf2Xdb5flGwA+b3yxpLDks0zAe4LnnnuvRP/788y/0pq3WDxbs4XfTFy+89NKAfbZ1rqf/r/XVyzOmD+jn22sN5Hc6c9bMAfts61xvv8+JEydOIK/H0dP3qBfHtpykjYHry8sHImKFyr69gFPLy8siYttO3n8o8M2BbqeZmdkwMjEiehyxtFuPR5W6ed1VNDUFOLZp22LA0/3VqEFqPPAgsBzwfIvbYvPP3+fQ4u9zaBmO32evfs92CzweqzxfpGnfxC6Oe1VEzABmNG0e2L7fQSBTY4DsDhvyv+9Q5+9zaPH3ObT4+5y3tkoujYh7gMfLy4UlrVjZ/cbK8z/V1yozMzPrqbYKPIrTKs+PkrSEpC2BD5dtzwG/qr9ZZmZmNi/tGHh8B/hreb4T8ARwBbAgMAf4VEQM9ZyN3poBHMZrh5msPfn7HFr8fQ4t/j7noa1mtTRIGg98hQw8ViSLh90ITImIq1vZNjMzM+taWwYeZmZm1p7acajFzMzM2pQDDzMzM6uNAw8zMzOrjQMPMzMzq40DD7NhSNIYSUu1uh1mNnipUoa1PznwsAFTLm7LtrodNjdJC5OrOR8rablWt8fMBh9JIyMiJI2QtFh/frYDDxsQ5eJ2KfBNSau0uj2WJI0CzgBWAz4KHCxp+ZY2yoY8SSPLT5WfEyUt2NpWWVckjYqIVyQtAHwNmCLprf31+Q48rN+Vi9t5wGbA9sA+Dj4Gh4iYTVb+va1s2gcHHzaAKhexccCRki4F/gFcIWmnFjfPmpTva3YJDM8DDgXeD7yjBCLzrd1Wp7X2sDAwFVgdWAHYnbzZ+UFZ6M9aQJIiKwYeDrwA7A2sCXy67J8SEQ+0sIk2xJTu+sZF7FLg7cBMYAywLPBLSZOBEyNiTgubaoCkEZXv63JgY+AO4KvAxcB4SUtHxH3z8++4x8P6XUQ8C/wUOBp4GFgC+Diwr3s+WqcxXluCjxOBU4B/lt2fxj0f1s8q3fUXkEHHX8hzweOVw64AxrWgedYkIuZIGgOcRQYdfwU2B64EPkGeL26V9B1JE/r67zjwsAEREU8CvwSOwMFHyzXG1suJpRp8/BQHHzawdge2Am4FNgE2AJYEZgNvBZ4Hpkp6Z8taaFXrkEHiS+SirBOAH5XHUsB4sgekz8NkHmqxARMRT0o6p7w8CJhMBh942KU+pbv7lcqmMcD00gNyfNm2F3MPuxweEQ/W3FQbmt5Sfk4FjgE+SwYdW0bEzZIOLce8U9J1JQ/JalIZgm0YDywKBHnjuCCwDHkjOY3M91iGHEbvEwce1i+qF7dydz0yImZHxOOSziuHfYUc1929HOfgY4A1fS/7kXeYby7fyWURcX0Xwcd4SQdFxEMtabi1vXIeWAho9HDuRvZ8zgbeERF/krQW8Emy1+NWBx31apwfyqyj8WWY/G9k79T65Oy32cBBEXG0pHWAjwAzgLv6/O96dVqbX00Xt72ADYHFgduBb0fELEnLADvS0fPxKPAb4Ij5TVSyzjV9LyeSd5qvACOBF8mZBd+IiMvLReLzZI/UuuTJZoWIeLQljbe2U7mIjQBGRcTMsv1I4MvlsFeAz0XEDyS9CTgfWAk4Ffi0E0zrU5m9sgB5Xl4dODoi/iJpcfJ8EMBFEXGTpNcDFwGrAr8Gduzr9+XAw+ZL08XteGD/pkOuAbaKiJmV4ONLwIrA3cDbIuJxrF+VPI455fkJwH7ALOBM4INkV+orwN/Ju5lG8HEwOQV674i4vSWNt7bTdBH7CnlH/IuIeKDkbhxPBrSQCYsLkjcnSwCXAds3ghYHHwOvacrs/wHbAU8DJwHHRMQLjSGYct7eEphC9lhfAWzX6ClpGsbtmYjww48+PYARlecnAHPIqXL/W3k+B7geGFOOW4a8+7kdeGOrf4eh/gAOKd/BDOB1ZK/HnMpjOjnTYMtyvIDFWt1uP9rnQfZuQAYTF1b+39+VnMAwggx8/9r0t/cSWSdiZHn/yFb/LsPh0Thvl+/ruvJd/JO84RgNTCJ7oUaW88F3yR7QOcAvKt/XqL62wT0eNt8kfYMsMjMLeBOwKfBD8o+1kUd0I7BZZM/H0sCMiHimBc0dNiS9HfgVGey9GVgO+G3ZfRLwgbJtOjn0tWdEXFl/S61dNXooyp3zFcBGZN2HQ8lu+bHAC5F3128GdgbWBv4D3Ez2isxp3IG35JcYhsqU2V+QPdB/Bd5N3pzsBHyLPG+fQiaXjgS+SeZ0/LA/vi8HHjZfJG0K/I48waxLRsqNi9svyLueOeRdz53AOhExq/6WDn3N2enlRH8cOSf/MTKnBuCzkWPsN5PJpAuQdRU2joh7a262tTlJY8nu+u3JxMTtyN6MHcnu+YeAKyPigHL8uIh4ufL+vnXXW59Jegt5nh5PBhv/JgOO5imyn4yIU6uBRn98X57VYr3SyRjsLOAG4Bwyb6MRdHw+Ik4sWetrklM4VyfHCO+rr8XDQ1Ouzesi4u6I+Kukz5IXge+SiWI3RMQPytvGk3elK5AnGAcd1i3lisbTI2JaZfObyITyJ8n8jkWA7wEfK/snAWtJ+ldEnEoOw7zKQUdLjCCLto0Dvl9eL0tOmX2M7A1dgRyepdq70R/flwuIWY+Vi1sjYbGxpPpNZDGZPwKfKdsuKkHHQmTxmRvJXo+1wzNY+l1T0PE14ExJhwBExD+AZ8jqgwJWlHRUWS9jNTLZdBltSmUAACAASURBVNOI+HtrWm/toiwS9h9gP0kTK7smk8HFEmT+1mVkT+c55GyVEWSP6GhwoFG3RvHAJg+SU2aDvGGcDHwlInYBfkYuezGTzMXr/zZ5qMV6ounidjDwYeDQiPhN2bY4+Yc8GXiWTGp8Dzl2uDTwYkS82Iq2D2VNs1dOoiP4Ow74SUTcWfadQSneRtZMGE+OxW8REY/V2mhrO5LeANxCBhDTga8Dp0XEM5IWBc4GtimHB3kzchw59fJqsnd974j4v7rbPpw1TXEeCywGvBwRT0taiazJsTDw68hibquTvdaNKbMfGohA0UMtNk/l4tYIOr4P7Ft2fUzSjZHTYaeReQKTgYnAseQf+h0ADjoGRiXoOJwMOmaS3aR/iFJHofgVOYX2vWSy2L+BDzrosB56EXgAWJnMCToSQNJPS/BxIDk1eyHgrMjiYKuRF6/FyLVazuv0k21AVKbMjiMXhlyPDChekvRdsme68T0uIekTZJ5HY8rsh2J+psx21zb3eFhPSToCOJCcrbI9cFNEPFvJbN8U+DGZyzED+C/wvsZdt/WfaiJp6QI/h5yhsn9JHK3uXyAippcT0NZkj9RdEfFIq9pvg1+ljkPjArYicC5Z0RJy+PRg4EcR8XzlfUuSQ3tHknkCU4FtBuoiZq9V6emorgo8g7wZbJhCBiRBntf3J/Nz/hf4eHn/gMw2co+HdaqTGRLvIksezwH2iIjfN8YOS9AxJiKulrQFmc3+MPDn8DLr/abMHlg7Iv4Sc98xrEGe4F8GGgmiIyXNKT0iO0laMiKOJu9AzXpiYXJY7hVJoyPifkkfJmewrE/mbkwB5kj6UUS8KGlhchXTKeUzfgnsNpAXMXut6FgV+Fwy6PgzmfB7PNkrDfCzRk+0pLPIoOQ+4JSBnuLs5FKbi6SxkpYvdzrVpKTVyHoQM8maD+VwjSzjh1+QtH1EPBIR34+I8x109J+SqHsNcIak9Zt2Tyo/xwHvhMxCLyePccCngM+Uuh5m8yRpA3L583eXIHd2CT7uI/O7/lIOHUH2bLy/vH6ZLCJ2LDnD5WMOOlpmZ2Bbcghsc3KoZTLZY70REJIek7RORNwNHBYRPy7njZED+X058LBXlYvb74GrOwk+1io/x5I5HMCrGeqjgF3I2RRr1Nnm4aAEdseQy4m/BPxV0iqVQ56uPP+QpIMkLSVpXTLpb2OylsK/6mqztS/lQmA3kTV5fijpXV0EH38tbxlRjls9Il4pQ6uHRMT36riIWZfeWn7eSAaHB9GxKvBNZL2VSeRNyeiImN5440APhznwMODVi9tFwDvI7raHJC1e6dK/r3Eo8LMypLK4pBXI/II3kpH1U3W2e5gYQc4M+DHwNrIbu/EdQE5/awyhrEKO2/6FHNt9PznstUdEPFlno61trUL2XAAsT95QdBV8NPKExpLTMgGIiBmV587pGGDl/F19PYosZQBZT+UzZM2lt0fENWWW0kHAC8Afo+aijg48DHh1dsRPyHocWwGHAZeXzHTIcd3GEMvCZNbzjWT3//vIi9teEfFEne0eDsrd4jkRsQ+5dP2XyQBkX0lblO/uKOCSytsmk9/T38gps/+pudnWvi4lL1YPl9dLk8HHViX4aOR83AP8gExOHEPOXrGaNeorSRpdAorGOaMRFI4jF4T8duQqsxsCF5Pf6znlUW+bPavFmkn6FvA1cgrd1cABEXGHpLeRy1hPqhw+gywqtGNE3FV7Y4eRclfzAXLBrU3L5l+Tq0leK2kJ8s5mNbJnaipwaUQ81Ir2Wvsqiczbk4s/NpIRHwV2j4jLyzELkEOAnyKTmncIr2hcK829yuwPyQqyx0bETyQ1KpG+jQwOHyV7OCaRs1datiqwZ7VYZ/4GPEd21W0KHCfpcxFxXQk+vkrO9Z5BBia/jIgHW9baIar5ZFDuai6ioxt8U0pSXzkBXQkc5kQ+m18RMaP8rUFH8LE0cK6kPclAYy1gB7Ln/BpKzR6rRyN3pmnK7APAssqCjo+Ti7wdSA6hL1Pe+iJZU2XnVk1xdo/HMNdVpCtpW7Lo1HjyD/U64Aul58MXtgGmuSvFrk5+BzMi4okyU2ULcsil0fNxIfD9iJjakgbbkNRFzwfkuizjyIJhfwC2bcWd83BXvp9zySrRt5PD3vdHR2HB0WQp+/3Jno6nyVWBzx3oKbPdttuBx/DVdHFbEhgVEQ9X9r+bLCZTDT72i4h/q6No2Fz1Pmz+ae4y6N8j7ypHA/eQ6yn8uZPgYzbZ+3RYRFzTmpbbUFQubu8iu/KXq+yaQXbX7+gps60h6aPk9yLgPWXItXr+WDKysvRrVpVtZTE3Bx7DVNMf5xHkXc0EMrn0K8BjZTptNfh4lpyS+bGSWGb9rBrISToa+CJZtK2RCP4iWQXy+krw8YXy81lgHQ972UBQVi49iAw+HiXvnE910NE6ko4DPgc8Qc5Y+XfTDJfvAvdGxE9a0sAuOMdjmKoEHY2LW8NuwFLAwZJujYhLSlR9Jpm1vjx5d239rJMeqA+S/61PI3s9liS7tqeW2SzXS5pKziiYDhzsoMMGQrlRuR/Yp5N9rtNRgy6GsRpTZieROR7/rpzbVwf2AJ6RdOVgSv73dNphpszvbjxvzIJ4hazh8Th5d701OT1z3fLHfgnwP2Ti0rsj4r+1N3yI09wL8R0BnELWRdgjIj4NbELWSYEMNKZK2jgiXgZ+B3wkIm5rQdOtDTXXfWja95pl1LvL23CdjoHXNGV29cquZyrPvyNpT0lvKDV+LiZvIq8hF4UcNDzUMow03VGfQs7T/yJ50bpEuQ7D/mSlyxFk0tiXgdtKd+pC4VVm+01nY6ySziV7OqaR47ZbRcSfy75VyXoq61beslGpQmjWI5UpmKPJdX5WIddk+WdEPFqOcZLoINE0ZfYnwDZkov/PJS1G5tlUl1GoJv5eTt4sDqrEX/d4DHGSRpTkMCpBx+lkIaqvkX8DT5X9/0fOy7+e7PnYkvxDX6vsd9DRT5Tl6a+T9NnKtjFksAGZUzOBXG8BgFIE7EPk2Drkd/RcLQ22IaHpIvZz8q74ArIg4E8k7QPd93BYfUqw0Pi+fk8uTTEbWE9ZWfppMsfj5srbliDX1DqXjqBj1GD6Tt3jMYQpV4o8GbiWXIlwpqRJZDnt5cgSuiOBXSLinMr7diB7PjYrm1by8Er/KYHgpeSCbjdGxCaVfQsCJwJ7lk1PAkdFrizbOOb15FDMPhHxz9oabm2tMhOtcRHbhKxuOZvM3QL4B/CuxkwIa71yvvg/cgLAP4F3Aw9X82okLULW61iMHH65GbiglVNmu+PAY4gqd89XkqsQnhkRe0gaWwoDrUJWtNugHD6bLKt9beX9HyYTkw6ICBcG6kclt+YKsqdpG+A7wN0RcUrZ3xx8PAScGBHfq3zGoDuZ2OBXzgtnkD1pNwG7ltdvI3vQ1iEvXKPCq0u3VGOGm6SdydL0I8kejOuahs0nRRdLVbRyymx3PNQydK1BdttfD/yPpP2BnSWNL1NhdwZuKceOIpMVX102vQy7fMRBR/+RNErSopGLtW1VHl8n71R+WGYPEREvkT1Op5W3LgvsI+kbjc9y0GF9tA7Z03YPOVNqdzLomE3Wg7mPPGccUKZrW4tU6iNtQJY4n0Pm4gDMkTSyTBb4hqTduviMQRd0gAOPIacxayUi/k6uobAp8C3geHKNj60rwcdOzB18XCZps8ZnRcQLNTZ9SCvDXucBn5e0RLlDWZi8CDxH/r94lqRdoNPgYyVgp5JMZtYjncxeWZ8snT0TOInM85pNDq9cT85oWxFYm/z7tNZr/D8/EWgsAhclqFiJ7LU6Sh0Leg56DjyGkJKw+GtJB8OrwceKwHpkPsd6wMHANp0EH7PJTOhzJI3rbEqd9U2ZPXAF8F7yv/cnSvDxHJksdhl5JzOCXAW0Ofho5N/sVJLJzLokaaHKDcgcSWNL8S/InKGZZI/ojuR54U0RcXUZgj2xHHdxV933NjCaz7mV19VFHs+U9FFJ65cps5eRvSEXkYt1tgXneAwRJQHpLjJJ7B7guIg4uezbhOz92JksvX0LuXjQZRHxvKSVyQvjosCmEfGPFvwKQ5akpYFDyJyZhcgTxKnA6ZFrr0wm18LYmpzNMgf4eEScXd4/DlgkIh7p5OPNXlXyh3YBlo2Ir5Rt15PrrLyTTCq/kswXmE3meewNvBU4lLxR+RWwa3hJhNo0cjFKD9VCZK2elyPipTIh4AZy2nPDc+R3OGinzHbHgccQUXo7ziWTFecAD5LLI59Y9m9CVh3cic6Dj5XIv4d762/90FR6OjYma3K8BHwcOAAYy7yDjxnAvhFxeivabu2n3HwcQPaSjScTyN9IDq/cSpbUflHSgeT/+w3TyYtYo2duu2jRqqXDUWWK8ziycOMGZKB4LXByqVC8LjlUWw0+niZrLe0SbVa23oHHECJpArlg0EeBICuNHhMRJ5X9zcHHTeQ476+dz9G/yknk+8CHyZP6TmT1wN3Jom2N4OMU4Iym4GNzclz3aWCVMiRjNk+S9iL/piCHUUaTq5a+qXpHLOnLwLfJBPTRwN3AVcCn2u0i1s4qPR3Vpe1foaNH6gGyevE1pefj02Sy+RPAX4ELB+uU2e448BgCqt2hJfj4MfARug8+PgAsSJ5s3hcRz3f22dZ75SRyCZnYew/53/j0yJUjVybLz3cXfJxOjsG/x8Ne1lOVoOIA8s55NhlYnB0Ru5djXr1ASdqILDY1kewRub1M32yri1i7qnxf48jzxTvJZRF+TfZcjSaT/h8gh16v6mzoqx17phx4tLmm+dwLljHBhclu/J3oPPjYmFxlciMym91rfPQTSQsAF5JDJrcDO0TE3U3HdBZ8VIddlibrKHjBN+uVUqfjInIZ+4anyYvZ/lGqD5eh2TER8UzT+9siR2CoKN/X6WQv9c1k8HEM2bMRdFQy/i+Zd3PdUMi78ayWNtYUdOwLfEHSOmXYZG9yjFdkwumXJO0HEBE3AIcDb3bQ0X9KFvqXyKDjv2SPxd2NKY2NnyWP5lTgWDKXY1Uy8XTfMtvlUQcd1keLkkMs15EJzZDDdjuQf29IWpScDfEtZcXLVznoqN27yNlFdwPbkjeEnyZ7q/Yli7kFsALwB0lvbPegA7Ibx9pQU9BxPJlQNhN4TtJDEfGUpE+Xw3cmg4/9JY2LiKMi4k+tafnQVbqpG+XP/wY8JGl0RMwq+1+dJRAR90o6g0wE3p8cWnkvmRdi1iPN3ewR8VgpJvVSREyXNJ28g14U2EXSmuTMlhXJaZrTWtFue9WjZDn0nwOfIAsKzga2LHkdnyeHxMeSPSJDYokED7W0OUnHAp8n75z3Aa6o3i035XwA3AZs1tzFavNP0lrkf1+An0fEx7s59nXAysD9wGfI72dr90BZT1VmQyxAJjG/mZzN9peIuKpy3P5kAUHo6L7/I7BNeX/bd923szL0OgM4ixxquTQiti/bryODklXJOj6z2zGno5kDjzamrOF/Otlz9YGIuKhpf2NtloXJufnbAWuFy6APCEnrkD0dc8g7k/dFxH1NxzQSyr4LfIGcwfIQMMMFm6ynNPcqs+cCW5C1H2aTd9Ffj4ifVY7fDTiOzPe4FdjZs1fq0VVg1zQpYEWgUcrgGeA35LlhBWCdRpL5UPm+nOPR3tYnu+DuAm6EjjyCkrS0jaR1S87HR4DlHXQMqAfIsdoR5NDJNqqUrC7DLnNKYt/bgQXIQk8POuiwnip3vNWl0rcFHib/9kaRQyknS2osMkhEnEVWLt6MvHN20DHAJL1e0hvKEOxrKkFXg5GIuB/43/JyUbII3ArABVSGV4bK9+XAo02Vk85by8vFyK64anLYMsBhZHnuxSPihYh46LWfZP1oFlmrA/ICcAL5338yQETMKkWefgG8gyzWdE0rGmrtqwQNC5DJ45sAfyZ7PO5sHELmBRwv6ROVtz4QEQ+XC+GIoXIRG4zKVOXrgJ9JWrOr4KMc29j+ffI7hSxt/2tyoc45eu2aO23NQy1tTNJ5ZD2OGWQexykRcXvJVD+NzGQ/F9gzXCCsFiV57zqyNgJkMPInslLsWGBdchrzg2SuzT2taKe1r3IR+grwXbKI1DvINZgOIYda/kUu8gZZWvuQKMsn2MArQ9t3kIW+ppH/7+9fzs3zzKeR9FZySOyeaMPiYD3hwKMNNf54Je1IjtsuR5Y9vgN4BFia7Fb9L7CFL271Ui7edD4woWyaw9y9i3eR+R931d02a3/lwvZV4P3AbmTu1rfJoOPtZA/o+WQBqpFkWe2tnUBaH0nbAGcAS5HLJfyJXgQflc8ZknVVHHi0IXWU2V0K+CbwQWBJ5i44cw9ZR+LOLj7GBlBJND2JnLa4Qtn8N+B64HtlTNesT5RLoL+uvDwdmATsExGnSPo4WadnDPAU8EbPXqlPJfF3MzKpfxJZ6uA6+hB8DEUOPNpM5Y96SbKn43ayCuZu5EXuv+TF7YTmGRVWrzLktRDwevJu9C/AnIiY3tKGWduo/P8uYHREzKzsE1nx8ufkkN55wI/IJMU7ySm2zwzV7vrBqPJ9jSX/v9+bLAQ2guyVvgEHHw482knlj3oZ4GryjufNEXFrmcWyPJndPrtRtMoGl+F8srHe0dwLiB1N/v9+P/Bb4HflXLATHQmJ08kAZDx54/GF6ufU/xsML5Wp8tWVwp8gv5NFyITfPg+7DCUOPAax6vheU9BxJbBa+bmVTypmQ5NyAbHLydkrDbeSM6NOJHM4jgM+Wdl/OfDuErQMywtbq5QbwIuBLclep3eRvZ5rkYtBLkYGiNeTwceQqETaWy6ZPoh0cmcygkxMpAQdS5FZ7EsCU4Fty8nFdzRmQ0Slp0Pkuh2bkEXBXiCnza9L3j2PIMuhf5mcUrsq2eP5A9fpaJnXAW8kczoujIiHSvB3V5mNdCYwDtgYOFvSDsNxSNyBxyChudde2Z38491U0h+BGyLiQjJqHk+eZLYtwYhPLmZDRNPwynZkd/3DwNvIGRIfISverkbmdgU5rPLTTj7H54X6LUveGAIsDq+u4SSyENjz5HV3HFmr47+taGSreahlEGgKOk4A9qvsnkHe2RxCri65CXCjgw6zoakEHXeSF7HZwC8j4uPl4jUZ+CIZfEDW7LgA+KbPBa1TKXGwPDl9edWya/dSNbaxPtOfyZkuy5HLXAyJtVd6yz0eg0Al6DiGDDpmAUcCHwNWKoc9XfI9ri3HOugwG5o+QQYYkOfo1SS9LiLuJlc8Pobs6fgiWZp/FWBYXbharZtg4SmyZ6MRePxM0uZkQbAPkUmmP4yIv5fPGZbncfd4DBKSPkxGwrPIP9rNyQI0kIljPwe+Bfw2Ilxm22yIkrQSsCc5FXMpsvrlUcDPIuLhcsxkckmENwMbuU5HfZqmzG4HrEOuu3R9RFwkaSK5FMLalbfNJOuqXAh8aCgWBesN93gMHuuWn8eQGdGnldefj4hTJX0G+BLwrKQbPV3WrP11VpkyIu6TdBo5xLonWYn4i8BsSb8o6608LOlg4KnSxT8s75zrprkX6DuPvEEcU9n/c+BAcnn704A3kPU8ngZuJhfomzMch1eq3OPRAk1FgRYgp1ddTSaQ3UN2nQLsFxEnlz/yy8lM6E8Cpw33iNms3VXOA6PJ2RBrkj2e10fEU2UW2350BB9PkkOw50TEA5XPGZJltQebSh7HOOAysjz9HcCzZOL/BDIn5w0RcXep5zGR7MF+FPiPi7mlIbXiXTsof7yNP7ojyQg4gD+WbSuXnweUoGMMcA4ZdEwFfuOTjFl7qwQdCwJnAReRRad+Ddxcyp4/S65Yeho5s2UJ4HvkonCv8vlgYJUbxMbslJFkMbe3k4mi65ErUk8gJwK8FVhG0nsi4sXSO3V1RNxVgg6vCox7PGpVHYOV9GUy8HgQ2Ax4C3AysCi53sqlZALZ0uQ47gPA5uEF38zaWqXCZbUn8wVgYfKOeRS52ONBEXFWJefjEHIWyzrDuZu+LpLGR8Tz5XnjOxtP3gCuDGxFlqU/iPzetoiIayVdRQaHa0XEHS1q/qDmHI+aVLvXJK1OLlk/E/hMCSbukfQGcix3YWDbytv/DbzXQYdZ+ysXsDFkwvjG5CyIQ8j6D58k8wKWAb4t6eKS8/FT8ubjNBcHG3iSNgAOkHR6RFxW6VVaAVifnEV0JjnEMhvYpgQd7yBnGv0HGNuCprcFBx4DrNHLUQk6ziR7MdYEvh8Rv5W0QERMj4hDJT1EJiy9k7y7uQn4UXg1U7O2V+n13BjYEHgG+HhE3FL23wr8kCwguAKwEXBJ+f//lHKMi4MNIEmvJ8+7ACMlzYqIqeX1K+SQylgy6HgF2CAi/i5pZXLYbBJwKlna3jrhwGOAlPK4IosA/bds+wpZm6NhAkBETJc0OiJmRcQpwCmSloiIJ31nY9a+JK1FJo5eHhEvV6a7rkn2akAGGLcARMRNkk4BflD2veYc7WGWAbcSuTTFm4EdgVGSiIipEfEvSb8Edi/HPgLsLmkmeW5flszT+UbJCXHibycceAyAkvX8DWAD4I2SbiIj4RHkssgbl0PXkLRRRNwYEbOaplg9XX76JGPWhiStA/ytvFwXuK2ye3z5+TKwpaTbSoEwyCJUL5EJpXfW0Vaby1Xk0NeBZP7d+4ER5fx8OXACGTRuTVYg/QK5ptYI4PdknQ6vodUNBx79rEyhuoS5M8+3JwsBnU4WBRsHvInMjP4fSS9FxN+jsppkI0p2QSCz9iNpAbLuDsBPgX9I2hS4OSJeIpPH9ycrlO5GXtimAg8BR5CLwF0P3FV324czSWMiYoakK8nk/olkz8d7y/4ZEXG1pAPJ7+pDZBB5LTnL5SDn4MybZ7X0oxJ0TCVnqDwEPE5WrxtFDrv8AdiFXPjpc2SSEuSJ6cSIuK35M82sPUl6K5loeBbZ2/EGsuv+d2SOwHfI88FiZM/HOOA5cgj2D3SsPu3u+hqoY4G+hYCvkYUcV6ejdwrgt8AxEXF1ec+qZE/HfyNievVz6m19e3GPRz8pf6xXkfO6/0ZGwo+Q6y5MIe9gtiS7XH9FVrvbhww+9gLGS/p2RNxef+vNrL9FxE3ATZIOJXM6ILvpR0TE+ZKOJe+qP0jmBkCuXnoJsJvvnOsVHasC/54cDr+XHEZZj7yZfAsdPR9jI+LyiPhP9TNKj7WDjnlwj0c/KEHHn8iTyxPAu6q9F5LOJ6fPPk/W4rilTKfblVyPYSNyHv/qEfFI3e03s/7TvGaKpLcAnyfX9ViE7A39fEScV+pCrEhOn3+GHFq5zhUuW6OUof8uWSV2m4j4azlXb0fmfWxQDr0QOCUiftealrY393j0j6/QcUcjYC9J369Ew8+Vn3cAz5Su05mSfkGWTH8Z+JyDDrP2VumuH0WeE/4ZEX+WdCQwkhxmXRY4XlIAF0fEP4B/NH2OK1y2RmNV2Vlk5VjKufp3ZPDRCDx2IMsdOPDoA5dM7x8/IRNHp5NljXchi8+MlbQr8PFy3MkRcW+5m1FEzCTzOz5YTj5m1qZKD8UrZVbbcWTdja+U7X8n76QvI1ebXbYcs13p3p+Lczrq1SiLTsdN4jLkDSWQwQc5hP4iWR7hDnLmovWBezz6QUQ8KOlrZCC3Mxl87EAmkzVmt3w2Is6CuRYbagQfM1vRbjPrH5p71dJfk/lcz5DnhInkKrK3SZpS3rI1sDyZ77UVuUik1aQ5YbcyNFa9AdylBCTHAouTCaf/JBfuu9nDYX3nHI9+JGkZ4HAy+BhLJo4J+FpEHF6Occaz2RBSuZFoJCZuQl7APhkRN0pajaxEen1EPFqKin0V+Ch55+y1V2qkjgX6xpL5dSPJlWMbhR5PIRP+Gx4lh8QXAQ6PiK+V4zzbqI/c49GPIuIRSV8lg42dyZkrzwNLSFo2Ih4iC82Y2RBRgo5RwIlk0HFb+blgJVkR4L+SPlbW9DiOXM/j2y42VZ9G7kwJEi8hZ6wsDFwj6byIOBE4mLxp/J/ytqXLz6nAN8vnyEFH37nHYwCUno8pwEfIno8ngPOAI73mitnQUy5kU8ll0X9EDqF8CXgPubbHDHLI5Xpg0+pFy9319aj0TI0CzgXeR8eqwEGuFP79iPheOf4T5HD5QsDdwAme4tw/HHgMEEmTyTudxrDLHPKO6ED/0Zq1t+ZudkkrAH8kl0t/jqzbM4Jc8O1asmDgRsB5EfHh+ls8vFWGV0aRvVHnk1NmzyLrc7yvHPoIcFJEHFHeN1dPlHum+odntQyQiHiYHMf9RWMTucqsgw6zNlYuPnMkjZK0LkDJDzi2HDKOnI75qYjYjwxIVij7/ll7g4e50tMxu9RMORc4lAwMPxYR3yUXdzu1HL4MsK9yQc/XLMjnoKN/uMdjgElajhwzPCki/tXq9phZ31XunMcBRwGbAxdExNfL/s3IZMV7I+IeSW8iL3arkOuzvNcXr/pJGk2WoX87WfZgAWCriPhD2b8gOb15b/ImcQ6wR0T8ovNPtPnhHo8BFhEPksXBHHSYtbGmKbO/BT4DTCKXTV8CICKuLBezBcpd8+/IoOMyStAhaWSLfoXhbFEyv+YZMuiYBexUhsQpC/d9AfgxOTngJuCXrWnq0OceDzOzeWiaMnsZ8DbgdmDvMmV2DXLF6RvIAlNbkD0dI8kL2D5OTGwtScuTxRwPJBd+e5AcYjmlUTW6LH/xGeDYEmQ6p2MAOPAwM+uB0lNxMvBJ4O/ApmQ+x17kSrOQ9TsOjIhLJW1Hzog4v+SE+CJWg0rZepGB3+iIeLnsW4lcI+vL5CrAD5DVo38SEY82fY6DxAHiwMPMrAfK3fBUchbEj4GzybLa25GltEUGGldFxOZN73WxqRo05eAcQE5vfgX4a0QcVo5ZmVzWohF83EfOcpkSEU+1pOHDjAuImZnNQ7l7XoiOvLi9gT3JO+ofANeUbVsC05pXqHXQMfA6ycGpdXjtKQAAGwpJREFUBn/vk7R2RHw4Iu6VdDaZRPpFYCVyGvTTtTd6mHJyqZlZE0lznRsjPU7mazxN3kXPIsui70eutfKGcvjfw13JtaoMr4wjZw9tTubgXFgOeQXYUdL5ABFxL9ljdSpw+f+3d+bhdlRV3n5/GUiAAJFBSZgiAmKYRASZQUABAUEBGTpAGGwURVRkkEZFu23br7VVwOBnCwkoo/CkCdBMDYQwtszz0GKSJgkBEsYkJLlJVv+xVpFN5dyb8Z47rfd5znPu2bVr196161atWtMGjqjWz2p+73seaWpJkiQpKNT1fXFhYk3gHTN7NLbvjT/IXjazl2ohs7cCB6YvR/OJtVf+CBwGPIQvxPeveOrzBSx80R5tZofGPoOAqVVG0/TpaA4peCRJkgSF0LEK7nT4GVwVPxm40szOLOpuAhyKp0ZfmyJPRzqSNh9JxwEjcQffXXAfjnNxzdTlwHBcYOwNjDOzPYt9lVqq5pGmliRJEhbxEfgvfK2lgbF5XeB7kn5T7LIV/ja9Ei6kVEJHnxQ6mkuYSKbj8/Yd4Gu40DEPN7t8HU+HXgkX65TmtBQ6mks6lyZJ0uOJN97KR2A0vq7Kw3jOh0twwaM3cGpEqJxqZqMlVQLGjUXIbKrr25kGzrsm6Q48Nwd4GnQDfm1m90vaGdd2jMPTom8T85XRRh1AmlqSJElwMwtwIZ6n42E8T8ePcZV96SMA8NtwKi33z4dYEyjMYb2BtfB5mWNmb8b2T+OZR8EFkZ/jYc99zGxwuUptCokdQ5pakiRJnI/heR9eBQ7BtR1n4Or6bYGbot584BuSvlPunEJH+1OYw1YFrsbzqjwCjJN0SAiPL+NmFYD18cX71o86ldChFDo6jtR4JEmSAJIG4H4d03DTykW4kHGgmd0q6XLgQDzd9v3Anvnwaj6S+uMhsLvwQU1UC/ADfLG3g/Assx8B3sNXCD44zGmpmepgUvBIkqTH0VrUSSydPhM4HzgFf3PeB19c7FHgF7jvwAXx5p3q+iZQmFcEHIf73YwH/hvYDRiMZ45tAQ4zsxskbYxrsN4Ebg+fjpyvTkAKHkmS9CiKh1h/XIMxCHgbuMvMXg51/f3Ap3EhYzy+oulg4Cgzu7psp0MG0YMokoOtimeL3QNf3n5bM3slVpj9A7Bf7PIEsLeZvdGonWb2PWlMCh5JkvQYKjV7hMzehufpqJapfx04zcyukvQlPEtp32L324AD8uHVfCLa6Gk8tfls4H4z26eYz8G4Q+lgPOfKdpFpNumEpHNpkiQ9gnAoXBAajYuBnYEZRZV1gBGSvmJmo/GEU3/F12G5hBA6IpoiaWdq6cv3xbVOAP2AQZJ2LEJipwAP4D4f03HfnKSTkhqPJEm6PYV5pQ9uQrkeX3PlHGAA8H38bbof8Br+xjxZ0urAzErLkeaV5lDMVz98Bdl38dwc3wS2jmojgYsjT8dHcQFxML4GyzGZFKzzkoJHkiTdmiKEcgCe2XImvrT9583swaizDW5a+XjsNszMrigjIDKtdnMozCcDgAeBC83sd+GTMwzPQrptVH8RdwDeBs8yezuumZqX89V5SVNLkiTdmipZFPAnPMphV1zL8dGizhP4gmIVq0X5grKdpnS4hxNCx0rAGGAo4WdjZrPxObwIeDyqbwZ8CrgOONzM9i2ijXK+OikpeCRJ0hNYGXgMf0Pui/sA7C7p40WdWbjPxzxgatN7mJT0xZN+gWszKvNLJXyMAJ6M7avhZrMXqp3THNa5ybVakiTpdjRYy+NdSRfggsXJwCbA8UAvSfewMLV2ZY65sfm97rmUvjNhapkp6VF8nirt07zYNjuSufXCc61sjWeYXV3S783ssQ4aRrKEpOCRJEm3oraWx9rAO8A8M3tD0qV4oqmvApsCJ8bf7+C5PC4GTsml7ZtDFSEU8zUAF/5el3Qvvg4LwA6x/sqTZjY36r8naSSeMOybuM/HycB7kp6p6iWdk3QuTZKk21Akm1oFj3rYEtdy/Cfw72Y2RdLaeKjsyfj6LAuAPwO/KZxNV8qHV/shaT0zm1z8HgCMxf01AOYCc4BV4u/ZeCK3t3Dt1HTgUtx0djRwLrARsJWZPducUSTLSmo8kiTpNoTQ0Q+4AfgsnnlUwBBgqKTTzWySpFGxy9eAjfFF4SZImmpmE1LoaD8kbQs8Iuk6Mzs8ig/FhYlH8HwdGxImFtw/Z2VgDRb6JT4InG1mLZKuwP1y7jGz8U0aRrIcpMYjSZIuT+nTIWlXYBzwEh79cDD+kvUu7r9xWggfleajMrvMxLUk/2ZmE5o9hp5ACB1jcaHiWjP7Sm37yrhwsTG+BsuFwERcYzUd2AnPs3JcmGf6mllL80aQrAhS8EiSpEtT+HRU+R+Ox301tgaeAQ4HLsdTo7+L53r4dggfa+HCx/F46OZrwNaZbnvFE0LHOGBV4DIzG96gTulkeiAeUjsL2NXMHo8w25YqRDqjV7omGU6bJEmXJXw65sUCYr+XdCfubDgN6G/ONXjiqfn4m/ZewB8lfdjMpuNCytXAw8DnUuhY8UjaDs8suojQIWkDSQfDImGwzwFTcDPL0Ng+N4QOpdDRdUkfjyRJuizh09EfV8XvVtt8Ai5MYGZXSzLcIXEgHg0xPba9Jel84Lf1FU2T5UfSDsCduKPonTWhY1NcIOkn6SAzu7fYdWZVDXcCfp9MDta1SY1HkiRdjshEWrEFLnS8jCcJq/iapF9VP0Lz8XX8QfeFcsE3M3s7hY4Vj6QP4xqlVfAold6S9ottHwXuBj4M3F0TOsDNXi3AvcDPmtbppN1JH48kSboURcjsADzR14vAQXg69GnA/8dNKxW/NrPvNmgnfQTaGUlrAN8A/g74BG7uGoeHL/8I+AhwvZl9qdhnIDA/kr59B1+rpSXnq/uQgkeSJF2OiH64H0+n3YJHsOwWPhtEorBj8BwdvYBRZnZCB3W3RxPCxwl46PKm+Jy04CsBjzazQ4u6g4Bngb/hDqXvRXkKHd2INLUkSdIVWR9PGAW+rsdGwObVRjM7DriMhfe4HSTl/a4DMLO3gUuA3wH/g8/JSrh2amRVT9J6eKhtla9jTtFGCh3diNR4JEnSJSiWt6/CZrfGo1Gqhd7ewrUezxT7jMEdE7cpQ26b3/uk0HycwsKMsfcAP8F9cx6K8juB/XK+ui8peCRJ0qlpa80USZ8CrsCXR4fGwkclqKS6voNpYHaZjwscGwGDcI3H54ul7XO+uiEpeCRJ0mkpkoP1A47Ak4INxP0ArjazyQ2EjzfwfByPFe3km3MnoYHw0YKby8YB+6TQ0f1JwSNJkk5JbcG3a/GQ2VVj81zcAfFAM/tbZMW8HH+Q9QZuM7P9OqLfyeIphI+/x01l9wGfTaGjZ5CCR5IknY7Cn2Nl4DZgF9wZcS6wLgudRp/DVfOTJW2F54V4FtgzH16dmxA+voXnYRmWQkfPIQWPJEk6JZEkbARwEi5MHICnz/4kbloBj3w408wuiH0+BkwITUk+xDo5kYtlZq690rPIlOlJknRW1gC2x5e2v9zMJob55fkIjb0MzwWxJbzvx/FS/N07H2KdHzObAe9ruHK+eggZ154kSYciabCkIyXtUUuFPhRPECZg9SizEDqeAF6NsmkApfNoa1EwSeck117pWaTgkSRJhyFpKHAVbjq5Gdi7SPQ1Afjf+PtUSXuY2YIQMFpws8sM4OloS83se5Iky0aaWpIk6RAkbYM7jq4D3I4nk3qu0FzMAiYCG+KLjN0k6SLgXeA4PKx2NJ5ELN+ak6SLkM6lSZI0HUmbAbfiiaOuBI43s7mxrRcuR1gRqTKw2N1w88t/AftXq8ymeSVJugZpakmSpGnIWQU4HRc67gaOMbO5lakkzCkWwsRTwO5Rb2I08yhwIQuFjj4pdCRJ1yFNLUmSNI1KoMDzcgA8HenM+5pZS63u/Ph+WtKXcHPLRsALwJuFcJLREEnShUjBI0mSZrM9HrECsQJpXeiokPR5PKJltJm9BUwptik1HUnS9UhTS5IkzaZvfC8AtpM0qF6hiFA5Bs/XsU29TjqTJknXJAWPJEmazQvAJPz+szNwQBFCS5hdTNIWwJ54dMvKHdHRJElWPCl4JEnSbN5mYX6Ovrij6EmSNo4yk7QpMAZYD8/zcX/Te5kkSbuQ4bRJkjQdSVvjy6BXGUnnAS8CTwKrAdvhi8Hdiq9AOz+Xtk+S7kEKHkmSdAiS9gKuw9dkAZiPL2lfcT1wWObpSJLuRQoeSZJ0GJEy/V+AzYBN8cRg1+OmlV9GqG2uWpok3YgUPJIk6VAioVgf3J9jvpm9WGxLTUeSdDNS8EiSpFMSeTryBpUk3YwUPJIkSZIkaRoZTpskSZIkSdNIwSNJkiRJkqaRgkeSJEmSJE0jBY8kSZIkSZpGCh5JkiRJkjSNFDySJEmSJGkaKXgkSZIkSdI0UvBIkiRJkqRppODRQ5H0GUmjJf2vpDmSXpX0gKRf1uqdIml4B3WzXZC0kqTfSXpF0nxJj7dRd5QkKz4zJU2QNEbS8ZL6NbPvbSFpePRxSEf3pdlIOkfSIUtRf4ikmyS9Eefs1+3Zv+K4fSVNjWMe1kqd8yRZrWyspLFttDu8dp229pmwYke0eCRtGGPastnHXhYkfVHSuR3dj+5Mn47uQNJ8JB0AjAHGAmcCrwCDgE8DRwKnF9VPAaYBo5rayfbl68DJwKnAI8CMxdR/D9gr/l4Z2ADYH/h34HRJ+5nZpHbqa7JknANcC/zHEtb/FfAZ4ARgKv4/0AwOBD4Sf5+I93lFcBOwU63sgWi/fJmYs4KOtzRsCPwIeB54ugOOv7R8ERgG/FNHd6S7koJHz+RMYDywb23Vz6skndlBfWomWwLvmdmFS1h/gZk9WCu7TNJI4Eb85r7jiuxg0u5sCfzFzJZUUGkTSb2BPma2uAf7icBc4G7g85LWXxFCq5m9Drxe6xPAqw2u3YZIWsXMZi1vX5JkcaSppWeyFjCt0VLjZrag+jvUslsAe9RVtZL6S/qlpMclvR0q6wckHVxvU9JASRdHnRmh4t442juvVndTSVdIei1MQM9J+saSDCr69DNJ4yXNlTRZ0m8lDSzqGHASsHIxpuFL0n4dM7sN13p8RtLutb4cEedjZoz5VknbFtu/HcfepME4fh79X7so20fSHZLekTRL0n2S9l6Sfko6QdITkmbHHIyW9IlanVHRzy3iODMlvS7pQvnqsWVdi/LjJb0g6T1JD0vaUc4ZMQczJN3ZyhgXO57K5BB9ujKus1clXSJpjbI/wKrAccWcjm3lXOwZ9TcB9i/qD4ntG0r6U+36O11Sr6KNIbHPmZLOlTQe1yR8djHzMBjYD7gB+Ff8/ju8rX3aC0lXSZomaduYhxnAfxbb95ebd96N+RnX4BrfXNKlkv4adSZJur68tiTtB9wTP68szvfZtX6U191kSafH9t3i/2hWXGtHNRjLevL7y5T4v3lJbnor52zzOO6pks6SNDGuz/skbVeeF1w47KcPmqjWje1HSXoortuZMfbfrYAp6VmYWX562Ad/WBpwPq5u7ttKvW2Bl4BH8Tf6HYFtY9sawEhcJflZYF/8ZjofOLZooxd+43kPOAv4HPBD4MXow3lF3aHAW8CTwDFR9xfR5o8WMyYBtwAtwE9i39NxM8qjQL+otyOulp5VjGmdNtodBcxoY/u+MY5zi7JzgAXAxcABwJeA+6MvQ6PO2vjD6p9q7fUGJgPXFWXDor3R0daB+MNrHrB3UW949GVIUfb9KLsC+EKc15fiPG9aG+ccYGL0/3O4erwFuKHWRwMmAPdFfw4BXgCmA/+GmzsOAI7GzRhPEAtSLuV4zotjPQ/8GNgH+A4wG7ikqLdjzOdNxZwObWW+Vo/trwD3FvX7AesAk4DXcFPcvsAF0YcRRRtDomwScCdwaJyvIY2OWbsuLOZBcQ7/Vp6bcty1srHA2KX8Pzfgwla2XRXnbCJwBv4/vE9sOzHm5xrgYOAg4GZcU7Nr0cY+wP8DvgzsHt834Nf5xsV94u+jL+cW53twrR/PA9+I8/inqP+PUX5czMUt0a8tiz6sD0zBr+mTok/n4dfyRUW9zaPN8biZ+Yv4tfdszPeqUW8T4PrYf8fi0xfYM9q4DBcg98JNdZcszbzkx1Lw6IkfXONxT/wTWdxQ7gPOBgbU6j69JDc8/IHZB/gD8GhR/oU4xtdq9c9mUcHjFuBlYPVa3QtwweVDbRy/EgDOqJV/Jcq/WpSNog1horZ/m3WLG9qI+L0B/rA+v1ZvAP6wu7oouy7G26so2z/aOzB+r4I/0MfU2usFPA78d1E2nELwAAYSD+TavhvgD+/La+M04Fu1utXDcpeizGIsqxZlB0f5Y3xQyDgtyrdahvGc18qc/jauh/I4M4BRS/E/MAG4sVb2szjeDrXyEfgDb7P4PSTq/ZVWhPYGxxPwP7iw0rs2vr1qdc+jOYKHAUfVylcH3gauqZX3AZ4D7m7jeL2BlXBh5p+L8l3jWEe20Y8vFGX9gDfxF44tivJ1o+5Pa9ftW4QgU5T/Q8zZx2r/pw/VrpvdovyQouwPwOwGfa3a7L8085CfRT9paumBmNl0M9sN2B4XAK4HNsNvvE+pUPG3haTDQ1U5A39bbcHflko1/h7xfU1t9ytrbfUH9sbfgmdJ6lN9cBVwf9r2o6icP0fVyv8MzIy22wPVfu+L36Qvq41hNm7X37OoOxJ/Y9unKDse1xLcHL93BtYELq211wsX1LaXtGorfdsJd4YdVRaa2cv4m3qjc3J57fcV8V03I9xlZjOL38/F980Wd+la+UbLMZ4xtd9P4tfDhxv0f3nYC3jWzP5SKx+Fz/NetfIxZtayhG3vgb9NX2pm86NsJP7QO2HZurvcGP7/VrI7LnzU5wfgVmBnSX3h/eiwH4Y5qgW/B8zBnUk/wZLTEm17p9xPZjww0cyeKcqn4gLJRsW+BwK3Aa/V+nszPmcfMA/hwmZ5fT4Z3xuxeP4SbV4b975BSzS6ZBFS8OjBmNnDZvZzMzscGIx7+g/BnU/bRNKXcWFiMq463wkXZC7BHwoVawHzzOyNWhOv1n6vhT+wT8VvROWnsj23JRBVx/mAg13cZKbG9vagumFNie8qYuEhFh3HEXxwDDfjmoPjASR9CFcBX1Y8nKr2rm3Q3ln4jXDNVvpWjblRxMYUFj0n88xseq1saq2tivp8zl1MeXVNLMt46n2qHDhXZsWyFq2fq2p7ydJEwpwY36PlPk8Dcc3CvcChKvyQmsibZja7VlbNz40sOj+n4f+jVV8vBH6AC/cH4Gbb7XHzyNLMzTvF9V4xl0Wvpaq8P7zv0LsWcHiDvj4S9ev3jGW+lszsduAw3J/oT8AUue9Uw7DopHUyqiUBwMxaJP0Yt6EvSbz9MPyt5IjyDUKL5rWYDvSRtGZN+Fi3Vq9Srf4RV6U3Ynwb/amOs04pfEhSHOuhtgazHHwxvsfG97T4PgxXObeKmc2X9EfgW/HgORpXM48sqlXtnQq0Fp1QF+IqqptsozezwUXbFX0krVUTPqp5qt+wl5XlGU97M53WzxUser6sXrERckfYQ+Nna9fh0bhJp5k06n81xpNx36hGvBnfw4A/mNkPy42hMW3z2l8RxP/PW7jZ+CetVFuhYe5mdh1wXWhod8bNL9dI+rSZtXa+khopePRAJA0ys0Zva5V6dEpRNofGbwMGzK0JHevitv6Su3ENyhHARUX5kR9ozGyWpLtwh9YnzWwuS8cdcZxhuOam4lD8DeWOpWxvsUj6HO7Qdr+Z3RvFt+Iq54/FTWpxjMT7fRTuo/GAmT1fbL8Pt2EPtSUP/614APeFGIa/lVb9Xh83GzTKIfF3uNNxxdHxPXYpj90ayzOetmjtOl0a7gC+L+lTtYfIsfj1ftcytnt09O0HuIajzp9xc0uzBY9G3I37y2xuZr9vrVII9Auo5QWRdCiLahnaS0MFrpnZDXjRzN5ZQW3OAfpK6t1AEwNAaIrulDQTF6A/SeuCWlIjBY+eya2SJuEe6M/jJrdPsjAK5DdF3aeAIyUdgXvgzzazp/B/+C9LGoE/wDbAb6yvAJsW+9+CP2x+KWl1XAW6E34zB795VZyG35jvkXQR7gC4Gm4bP8jM6jb2ktvxh/7P4zj3AVvj0RCP4ZqUZaWXpMq/pB9uw94fd1x9Lr4BMLMJkn4I/FTSxvj438RV2DsAM83sR0X95yU9gEefbIBHAFBsnyHpVNzmviZ+rl/DIzC2wSNyvt6o02b2lqR/BP5Z0mW4X81aeLTKbPzclMzFE6INwN/Md8YjEW4uBKvlYnnGsxieAvaUdBB+Db5rZi8sZRu/wq/Lm2IOJ+ImhFPwCIkXl6Ff4GaWN4FfNDBtEHPzXUnbmNkTy3iMFUJcM98Gfi9pHTxC6XXcn+aTwGpmdpqZmaSbgK9Kegl4Br++v8uiJqgX8WvrWEl/w32uJoXPxvJyDi5g3yfpAtyBd2VgY3zujq2bX5eAp/B74lmS7sA1sY8DP8XNgHfhJuY1cQ3xHBaGDCdLQkd7t+an+R/8QXk5fkN4F78pTMTDxD5Rq7sR/kB/hwijLLadhZs/ZuNhaSfR2CP/Q7jvx5v4Tec23B7cKIpiCB6GOin69RouRPzDEoyrP/AvuMAyF9fcjAAG1uqNYumiWqz4VCGIY3DfjJVa2e9g3IHz7Tg/E/A3270b1P1q0fbqrbS3Oy7sTY+xTYrfhxV1hlMLp43yE/GQ1jm4tuE/qIWbVucE2Aq/sc6KY42giF6JuotES7Aw0uN7tfI9o/ywZRjPebHv2rV9FxknLrTcG9eXsZgIEBpEtUT5hvj/xrTo1/PA9/hg5FHDsbZynK2j7q/aqPPxqHN+Oe5anbGLG1ODdhcX1TKtjX33wn2Q3ojr5mX8mi+jP9aM6+b1OO9jcQfwB4Fbau0di4dct0S/zm6rH9HGww3KpwLX1so+gvubjI85m4Y7gv6EiEBhYVTLNxvcM97vT1E2Msa1ILZX2txbcKFjTvRlDLDj0sxLfszDipKk2Ug6Gr/B72Jm93d0f3o6kkbhD/0BHd2XJEm6N2lqSdqdyDa4Hq7CXIC/FZ0BjEuhI0mSpGeRgkfSDN7FnUnPxR09X8FVtLkCZJIkSQ8jTS1JkiRJkjSNTCCWJEmSJEnTSMEjSZIkSZKmkYJHkiRJkiRNIwWPJEmSJEmaRgoeSZIkSZI0jRQ8kiRJkiRpGil4JEmSJEnSNFLwSJIkSZKkafwfTj/+nahHM2cAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plat_count = df_all['Current Stage of Development'].value_counts()\n",
    "chart = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\")\n",
    "plt.setp(chart.get_xticklabels(), rotation=45)\n",
    "plt.xlabel('Stage of Development for All Treatments')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Treatment Clinical Trial Phases and Months"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "#%% Get the dates for the clinical trials\n",
    "\n",
    "phases = []\n",
    "dates = []\n",
    "timing = df_all['Anticipated Next Steps Timing'].values\n",
    "for i in range(len(timing)):\n",
    "    if isinstance(timing[i], str) and ('Phase 1' in timing[i]):\n",
    "        phases.append('Phase 1')\n",
    "    elif isinstance(timing[i], str) and ('Phase 2' in timing[i]):\n",
    "        phases.append('Phase 2')\n",
    "    else:\n",
    "        phases.append(np.nan)\n",
    "\n",
    "\n",
    "months = ['January','February', 'March', 'April', 'May', 'June', 'July', 'August',\n",
    "          'September', 'October', 'November', 'December']\n",
    "for i in range(len(timing)):\n",
    "    for j in range(len(months)):\n",
    "        if isinstance(timing[i], str) and (months[j] in timing[i]):\n",
    "            dates.append(months[j])\n",
    "    if len(dates)<i+1:\n",
    "        dates.append(np.nan)\n",
    "\n",
    "df_all2 = df_all.copy()\n",
    "df_all2['dates'] = dates\n",
    "df_all2['phases'] = phases"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "#%%\n",
    "\n",
    "plat_count = df_all2['phases'].value_counts()\n",
    "chart = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\")\n",
    "plt.setp(chart.get_xticklabels(), rotation=45)\n",
    "plt.xlabel('Phases of Clinical Trials')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)  \n",
    "\n",
    "#%%\n",
    "plt.figure()\n",
    "plat_count = df_all2['dates'].value_counts()\n",
    "chart = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\", order=months)\n",
    "plt.setp(chart.get_xticklabels(), rotation=45)\n",
    "plt.xlabel('Months of Clinical Trials')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)  \n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Treatment Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div><table id=\"76b8eb5c-1988-4fd6-b4b9-7e7f125ef51b\" class=\"display\"><thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Number</th>\n",
       "      <th>Type of Product - Treatment</th>\n",
       "      <th>FDA-Approved Indications</th>\n",
       "      <th>Developer/Researcher</th>\n",
       "      <th>Current Stage of Development</th>\n",
       "      <th>Funding Sources</th>\n",
       "      <th>Anticipated Next Steps Timing</th>\n",
       "      <th>Sources</th>\n",
       "      <th>FDA-Approved Indications (Treatments)</th>\n",
       "      <th>Clinical Trials Ongoing for Other Diseases</th>\n",
       "      <th>Developer/ Researcher</th>\n",
       "    </tr>\n",
       "  </thead></table>\n",
       "<script type=\"text/javascript\">\n",
       "require([\"datatables\"], function (datatables) {\n",
       "    $(document).ready(function () {        \n",
       "        var dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}], \"data\": [[1, \"1\", \"TAK-888, antibodies from recovered COVID-19\", \"N/A\", \"Takeda\", \"Pre-clinical\", \"nan\", \"To patients between September 2020 and September 2021\", \"PhRMA Wall Street Journal\", \"nan\", \"nan\", \"nan\"], [3, \"2\", \"Antibodies from mice, REGN3048-3051, against the spike protein\", \"N/A\", \"Regeneron\", \"Pre-clinical\", \"Biomedical Advanced Research and Development Authority (BARDA)\", \"Start Phase 1 June 2020\", \"Stat News MarketWatch Reuters Bloomberg News FierceBiotech FiercePharma\", \"nan\", \"nan\", \"nan\"], [4, \"3\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Celltrion\", \"Pre-clinical\", \"nan\", \"Start Phase 1 September 2020\", \"Korea Herald\", \"nan\", \"nan\", \"nan\"], [5, \"4\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Kamada\", \"Pre-clinical\", \"nan\", \"nan\", \"BioSpace AbbVie\", \"nan\", \"nan\", \"nan\"], [6, \"5\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Vir Biotech/WuXi Biologics/Biogen\", \"Pre-clinical\", \"nan\", \"Start Phase 1 ~ July 2020\", \"Stat News Vir Biotech\", \"nan\", \"nan\", \"nan\"], [7, \"6\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Lilly/Ab-Cellera (NIH Vaccines Research Center)\", \"Pre-clinical\", \"nan\", \"Start Phase 1 in late July 2020\", \"Endpoints News\", \"nan\", \"nan\", \"nan\"], [8, \"7\", \"Avastin (bevacizumab), vascular endothelial growth factor inhibitor\", \"FDA-approved since 2004, approved to treat certain types of cancer\", \"Numerous trials with Chinese research sponsors; Roche\", \"Clinical\", \"nan\", \"nan\", \"BioCentury ClinicalTrials.gov\", \"nan\", \"nan\", \"nan\"], [9, \"8\", \"PD-1 blocking antibody; Thymosin\", \"Unknown\", \"Numerous trials with Chinese research sponsors\", \"Clinical\", \"nan\", \"Phase 2 primary trial ends April 30, 2020\", \"BioCentury ClinicalTrials.gov\", \"nan\", \"nan\", \"nan\"], [0, \"9\", \"leronlimab (PRO 140), a CCR5 antagonist\", \"nan\", \"CytoDyn\", \"Clinical\", \"nan\", \"nan\", \"Clinical Trials Arena CytoDyn CytoDyn CytoDyn CytoDyn\", \"N/A\", \"Treatment of HIV/ AIDS, Graft versus Host Disease, Non-Alcoholic Steatohepatitis, and numerous cancers\", \"nan\"], [1, \"10\", \"AiRuiKa (camrelizumab), anti-programmed cell death\", \"nan\", \"Wuhan Jinyintan Hospital\", \"Clinical\", \"nan\", \"\", \"Hengrui Medicine\", \"N/A\", \"Treatment of certain\", \"nan\"], [3, \"11\", \"Kevzara (sarilumab), interleukin-6 receptor antagonist\", \"nan\", \"Sanofi/Regeneron\", \"Clinical\", \"nan\", \"Started Phase 2/3 in March 2020\", \"FiercePharma Wall Street Journal Seeking Alpha\", \"FDA-approved since 2017, approved to treat rheumatoid arthritis\", \"nan\", \"nan\"], [4, \"12\", \"Actemra (tocilizumab), interleukin-6 receptor antagonist\", \"nan\", \"Numerous trials with global research sponsors; Roche\", \"Clinical\", \"nan\", \"Roche studies begin April 2020\", \"Wall Street Journal FiercePharma Genentech\", \"FDA-approved since 2010, approved to treat various type of arthritis, including rheumatoid arthritis, and cytokine release syndrome\", \"nan\", \"nan\"], [5, \"13\", \"Gimsilumab, anti- granulocyte-macrophage colony stimulating factor monoclonal\", \"nan\", \"Roivant Sciences\", \"Clinical\", \"nan\", \"nan\", \"Roivant\", \"N/A\", \"nan\", \"nan\"], [6, \"14\", \"TJM2 (TJ003234), anti- granulocyte-macrophage colony stimulating factor antibody\", \"nan\", \"I-Mab Biopharma\", \"Clinical\", \"nan\", \"nan\", \"i-Mab Biopharma\", \"N/A\", \"nan\", \"nan\"], [7, \"15\", \"Sylvant (siltuximab), interleukin-6 targeted monoclonal\", \"nan\", \"EUSA Pharma/The Papa Giovanni XXII Hospital\", \"Clinical\", \"nan\", \"Initial data March 2020\", \"EUSA Pharma\", \"FDA-approved since 2014, approved to treat multicentric Castleman disease\", \"nan\", \"nan\"], [8, \"16\", \"Soliris (eculizumaab), complement inhibitor\", \"nan\", \"Alexion\", \"Expanded access\", \"nan\", \"nan\", \"Alexion\", \"FDA-approved since 2007, approved to treat Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, and Neuromyelitis Optica Spectrum Disorder\", \"nan\", \"nan\"], [0, \"17\", \"Antibody\", \"nan\", \"Erasmus MC/Utrecht University\", \"Pre-clinical\", \"nan\", \"nan\", \"Erasmus Magazine bioRxiv\", \"N/A\", \"nan\", \"nan\"], [1, \"18\", \"Antibodies\", \"nan\", \"ImmunoPrecise Antibodies\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"Unknown\", \"nan\", \"nan\"], [2, \"19\", \"Antibody\", \"nan\", \"Harbour BioMed/Mount Sinai Health System\", \"Pre-clinical\", \"nan\", \"nan\", \"Mount Sinai and Harbour BioMed press release\", \"N/A\", \"nan\", \"nan\"], [3, \"20\", \"Antibodies\", \"nan\", \"AstraZeneca\", \"Pre-clinical\", \"nan\", \"nan\", \"PhRMA\", \"Unknown\", \"nan\", \"nan\"], [4, \"21\", \"Antibody\", \"nan\", \"Distributed Bio\", \"Pre-clinical\", \"nan\", \"nan\", \"Distributed Bio\", \"Unknown\", \"nan\", \"nan\"], [5, \"22\", \"Antibodies\", \"nan\", \"Chelsea and Westminster Hospital, Imperial College London\", \"Pre-clinical\", \"UK Government\", \"nan\", \"UK Government\", \"Unknown\", \"nan\", \"nan\"], [6, \"23\", \"Convalescent plasma (blood plasma from recovered patients)\", \"nan\", \"Multiple global research sponsors, including New York State Department of Health\", \"Clinical\", \"nan\", \"New York State Department of Health trial begins March 2020\", \"Politico\", \"N/A\", \"nan\", \"nan\"], [8, \"24\", \"Favilavir/Favipiravir/T-705/ Avigan, licensed in Japan to treat influenza\", \"nan\", \"Fujifilm Toyama Chemical/Zhejiang Hisun Pharmaceuticals/numerous trials with Chinese research sponsors\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Clinical Trials Arena Pharmaceutical Technology Chinese Clinical Trial Registry ClinicalTrials.gov BioCentury Guardian Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"nan\"], [0, \"25\", \"Kaletra/Aluvia (lopinavir/ ritonavir), HIV-1 protease inhibitor\", \"nan\", \"Global hospital testing (AbbVie); World Health Organization SOLIDARITY trial (studying lopinavir/ ritonavir with and without interferon beta); University of Oxford\", \"Clinical\", \"UK Government (University of Oxford RECOVERY trial)\", \"nan\", \"PhRMA Wall Street Journal Wall Street Journal Wall Street Journal Stat News\", \"FDA-approved since 2000, approved to treat HIV-1 infection\", \"nan\", \"nan\"], [1, \"26\", \"remdesivir, nucleotide analog\", \"nan\", \"Gilead; World Health Organization SOLIDARITY trial\", \"Clinical\", \"nan\", \"Gilead Phase 3 trial results expected April 2020\", \"PhRMA Wall Street Journal PhRMA post on LinkedIn Stat News\", \"N/A\", \"Treatment of Ebola\", \"nan\"], [2, \"27\", \"Prezcobix (darunavir, HIV-1 protease inhibitor/cobicistat, CYP3A inhibitor)\", \"nan\", \"Chinese hospital testing (Janssen)\", \"Clinical\", \"nan\", \"Primary study ends August 2020\", \"World Health Organization Wall Street Journal Chinese Clinical Trial Registry ClinicalTrials.gov\", \"FDA-approved since 2015, approved to treat HIV-1 infection\", \"nan\", \"nan\"], [3, \"28\", \"galidesivir\", \"nan\", \"BioCryst Pharmaceuticals\", \"Pre-clinical\", \"nan\", \"nan\", \"Reuters BioCryst\", \"N/A\", \"Treatment of yellow fever\", \"nan\"], [4, \"29\", \"Combination of ebastine, lopinavir, and interferon alpha\", \"nan\", \"Mianyang Central Hospital\", \"Clinical\", \"nan\", \"Primary trial ends March 31, 2020\", \"BioCentury Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"nan\"], [5, \"30\", \"Ganovo (danoprevir), hepatitis C virus NS3 protease inhibitor; ritonavir; interferon, approved in China to treat Hepatitis C\", \"nan\", \"Ascletis/Numerous trials with Chinese research sponsors\", \"Clinical\", \"nan\", \"nan\", \"BioCentury ClinicalTrials.gov\", \"N/A\", \"nan\", \"nan\"], [6, \"31\", \"ASC09, HIV protease inhibitor\", \"nan\", \"Ascletis Pharma\", \"Clinical\", \"nan\", \"Primary trial ends May 2020\", \"ClinicalTrials.gov Nature Biotechnology Ascletis Pharma\", \"N/A\", \"Treatment of HIV/AIDS\", \"nan\"], [7, \"32\", \"Truvada (emtricitabine and tenofovir, both HIV-1 nucleoside analog reverse transcriptase inhibitors)\", \"nan\", \"Gilead/Sichuan Academy of Medical Sciences & Sichuan Provincial People\\u2019s Hospital\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"FDA-approved since 2004, approved to treat and prevent HIV-1 infection\", \"nan\", \"nan\"], [0, \"33\", \"Arbidol (umifenovir), licensed in Russia and China for treatment of respiratory viral infections\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization BioCentury ClinicalTrials.gov Chinese Clinical Trial Registry Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"Pharmstandard/numerous trials with Chinese research sponsors\"], [1, \"34\", \"Xofluza (baloxavir marboxil), polymerase acidic endonuclease inhibitor\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"FDA-approved since 2018, approved to treat influenza\", \"nan\", \"Roche/The First Affiliated Hospital of Zhejiang University Medical School\"], [2, \"35\", \"azvudine, reverse transcriptase inhibitor\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"Numerous trials with Chinese research sponsors\"], [3, \"36\", \"ISR-50\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"ISR Immune System Regulation\", \"N/A\", \"nan\", \"ISR Immune System Regulation\"], [4, \"37\", \"Antiviral compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Cocrystal Pharma\", \"N/A\", \"nan\", \"Cocrystal Pharma\"], [6, \"38\", \"PLX cell product, placenta- based cell therapy\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Pharmaceutical Technology Pluristem Therapeutics\", \"Unknown\", \"nan\", \"Pluristem Therapeutics/BIH Center for Regenerative Therapy/Berlin Center for Advanced Therapies\"], [7, \"39\", \"Mesenchymal stem cells\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"BioCentury Chinese Clinical Trial Registry\", \"Unknown\", \"nan\", \"Numerous trials with global research sponsors\"], [8, \"40\", \"Ryoncil (remestemcel-L), allogenic mesenchymal stem cells\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"FierceBiotech\", \"N/A\", \"nan\", \"Mesoblast\"], [9, \"41\", \"MultiStem, bone marrow stem cells\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"BioSpace\", \"nan\", \"Acute Respiratory Distress Syndrome; Stroke\", \"Athersys\"], [10, \"42\", \"Allogeneic T-cell therapies\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"AlloVir FierceBiotech\", \"N/A\", \"nan\", \"AlloVir/Baylor College of Medicine\"], [12, \"43\", \"RNAi - testing 150 RNAis\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"NPR\", \"N/A\", \"nan\", \"Sirnaomics\"], [13, \"44\", \"siRNA candidates\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"N/A\", \"nan\", \"Vir Biotech/Alnylam Pharmaceuticals\"], [14, \"45\", \"Ampligen; (rintatolimod)\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"nan\", \"N/A\", \"nan\", \"AIM ImmunoTech/National Institute of Infectious Diseases in Japan\"], [0, \"46\", \"OT-101, a TGF-Beta antisense drug candidate\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena Mateon Therapeutics\", \"N/A\", \"Various cancers\", \"Mateon Therapeutics\"], [2, \"47\", \"Scanning library of antiviral compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"Biomedical Advanced Research and Development Authority (BARDA)\", \"nan\", \"Johnson & Johnson PhRMA\", \"N/A\", \"N/A\", \"Janssen Pharmaceutical Companies\"], [3, \"48\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"PhRMA\", \"N/A\", \"N/A\", \"Novartis\"], [4, \"49\", \"Scanning antiviral compounds previously in development\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"Screening completed March 2020, start Phase 1 by end of 2020\", \"Pfizer PhRMA\", \"N/A\", \"N/A\", \"Pfizer\"], [5, \"50\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Wall Street Journal\", \"N/A\", \"N/A\", \"Merck\"], [6, \"51\", \"Repurposing antiviral drug candidates\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Cyclica press release\", \"N/A\", \"N/A\", \"Materia Medica/Cyclica\"], [7, \"52\", \"Screening new drugs + library of antiviral compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"FierceBiotech Enanta Pharmaceuticals\", \"N/A\", \"N/A\", \"Enanta Pharmaceuticals\"], [8, \"53\", \"Screening drug compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"N/A\", \"N/A\", \"Southwest Research Institute\"], [9, \"54\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"PhRMA\", \"N/A\", \"N/A\", \"Takeda\"], [10, \"55\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"UK Government\", \"nan\", \"nan\", \"N/A\", \"N/A\", \"Queens University Belfast\"], [12, \"56\", \"Methylprednisolone / corticosteroids\", \"nan\", \"nan\", \"Clinical\", \"UK Government (University of Oxford RECOVERY trial)\", \"Primary study ends April 2020 (Peking) / June 2020 (Tongji)\", \"nan\", \"FDA-approved since at least the 1950s, approved to treat many diseases, including anti-inflammatory conditions and some cancers\", \"nan\", \"Numerous trials with research sponsors in China; University of Oxford\"], [0, \"57\", \"Chloroquine/ Hydroxychloroquine, antimalarial\", \"nan\", \"Numerous trials with global research sponsors; University of Minnesota; University of Oxford; IHU-M\\u00e9diterran\\u00e9e Infection and others; World Health Organization SOLIDARITY trial (chloroquine); New York State Department of Health (hydroxychloroquine with zithromax)\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization ClinicalTrials.gov BioCentury Endpoints News ClinicalTrials.gov Google Doc Stat News ClinicalTrials.gov\", \"FDA-approved since 1949, approved to treat malaria (chloroquine), FDA-approved since at least 1955, approved to treat malaria, rheumatoid arthritis, and lupus (hydroxychloroquine)\", \"nan\", \"nan\"], [1, \"58\", \"Camostat mesylate, transmembrane protease serine 2 (TMPRSS2) inhibitor, approved in Japan to treat multiple conditions including\", \"nan\", \"Leibniz Institute for Primate Research/University G\\u00f6ttingen and others\", \"Pre-clinical\", \"nan\", \"nan\", \"Nature Biotechnology bioRxiv Thailand Medical News Cell\", \"N/A\", \"nan\", \"nan\"], [3, \"59\", \"Jakafi/jakavi (ruxolitinib)\", \"nan\", \"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology/Incyte Corp\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"FDA-approved since 2011, approved to treat myelofibrosis, polycythemia vera, and acute graft- versus-host disease\", \"nan\", \"nan\"], [4, \"60\", \"PegIntron, Sylatron, IntronA (peginterferon alfa-2b)\", \"nan\", \"Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) (Schering)\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"PegIntron - FDA-approved since 2001, approved to treat Hepatitis C; Sylatron - FDA-approved since 2001, approved for the adjuvant treatment of melanoma; Intron A - FDA-approved since 1986, approved to treat Hepatitis C and certain cancers\", \"nan\", \"nan\"], [5, \"61\", \"Novaferon, Nova, interferon, licensed in China for Hepatitis B\", \"nan\", \"The First Affiliated Hospital of Zhejiang University Medical School\", \"Clinical\", \"nan\", \"nan\", \"nan\", \"N/A\", \"nan\", \"nan\"], [0, \"62\", \"Recombinant ACE2 (angiotensin-converting enzyme 2)\", \"nan\", \"The First Affiliated Hospital of Guangzhou Medical University\", \"Clinical\", \"nan\", \"Primary trial ends April 1, 2020\", \"BioCentury ClinicalTrials.gov\", \"Unknown\", \"nan\", \"nan\"], [1, \"63\", \"Cerocal (ifenprodil), NP-120, an NDMA receptor glutamate receptor antagonist targeting\", \"nan\", \"Algernon Pharmaceuticals\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena Algernon Pharmaceuticals\", \"N/A\", \"Idiopathic Pulmonary Fibrosis\", \"nan\"], [3, \"64\", \"APN01; recombinant soluble human Angiotensin Converting Enzyme 2\", \"nan\", \"University of British Columbia/ Apeiron Biologics\", \"Clinical\", \"nan\", \"In Phase 1 pilot in China\", \"Clinical Trials Arena Apeiron Biologics ClinicalTrials.gov\", \"N/A\", \"Acute lung injury, Acute respiratory distress syndrome, Pulmonary arterial hypertension\", \"nan\"], [4, \"65\", \"Brilacidin, a defensin mimetic\", \"nan\", \"Innovation Pharmaceuticals\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena Innovation Pharmaceuticals\", \"N/A\", \"Oral Mucositis; Ulcerative Proctitis/Ulcerative Proctosigmoiditis; Acute Bacterial Skin and Skin Structure Infection\", \"nan\"], [5, \"66\", \"BXT-25; glycoprotein\", \"nan\", \"Bioxytran\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"N/A\", \"nan\", \"nan\"], [6, \"67\", \"Peptides targeting the NP protein\", \"nan\", \"CEL-SCI/University of Georgia Center for Vaccines and Immunology\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena CEL-SCI Corporation press release\", \"Unknown\", \"nan\", \"nan\"], [7, \"68\", \"BIO-11006, inhaled peptide\", \"nan\", \"Biomarck Pharmaceuticals\", \"Clinical\", \"nan\", \"nan\", \"Biomarck Pharmaceuticals\", \"N/A\", \"Acute Respiratory Distress Syndrome; Non-Small Cell Lung Cancer; Chronic Obstructive Pulmonary Disease (COPD)\", \"nan\"], [8, \"69\", \"Gilenya (fingolimod), sphingosine 1-phosphate receptor modulator\", \"nan\", \"The First Affiliated Hospital of Fujian Medical University/Novartis\", \"Clinical\", \"nan\", \"Primary trial ends July 2020\", \"ClinicalTrials.gov\", \"FDA-approved since 2010, approved to treat multiple sclerosis\", \"nan\", \"nan\"], [9, \"70\", \"WP1122, glucose decoy prodrug (and related drug candidates)\", \"nan\", \"Moleculin Biotech/University of Texas Medical Branch\", \"Pre-clinical\", \"nan\", \"nan\", \"FierceBiotech Moleculin\", \"N/A\", \"nan\", \"nan\"], [10, \"71\", \"Rebif (interferon beta-1a)\", \"nan\", \"Institut National de la Sante et de la Recherche Medicale (Merck KGaA)\", \"Clinical\", \"nan\", \"nan\", \"Merck KGaA press release\", \"FDA-approved since 2002, approved to treat multiple sclerosis\", \"nan\", \"nan\"], [0, \"72\", \"nafamostat, approved in Japan to treat pancreatitis and other diseases\", \"nan\", \"University of Tokyo/ National Center for Global Health and Medicine\", \"Pre-clinical\", \"nan\", \"Trial starts April 2020\", \"Bloomberg News\", \"N/A\", \"nan\", \"nan\"], [1, \"73\", \"A number of synthesized nanoviricide drug candidates\", \"nan\", \"NanoViricides\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena NanoViricides Inc.\", \"N/A\", \"nan\", \"nan\"], [2, \"74\", \"losartan\", \"nan\", \"University of Minnesota\", \"Clinical\", \"nan\", \"nan\", \"ClinicalTrials.gov KARE TV\", \"FDA-approved since 1995, approved to treat hypertension and diabetic nephropathy\", \"nan\", \"nan\"], [3, \"75\", \"Activase (alteplase), tissue plasminogen activator (tPA)\", \"nan\", \"Beth Israel Deaconess, the University of Colorado Anschultz Medical Campus, and Denver Health (Genentech)\", \"Compassionate Use\", \"nan\", \"nan\", \"MIT News\", \"FDA-approved since 1987, approved to treat stroke, myocardial infarction, and pulmonary embolism\", \"nan\", \"nan\"], [5, \"1\", \"Washed microbiota transplantation\", \"nan\", \"The Second Hospital of Nanjing Medical University\", \"Clinical\", \"nan\", \"Primary trial ends April 2, 2020\", \"nan\", \"Unknown\", \"nan\", \"nan\"]]};\n",
       "        dt_args = eval_functions(dt_args);\n",
       "        table = $('#76b8eb5c-1988-4fd6-b4b9-7e7f125ef51b').DataTable(dt_args);\n",
       "    });\n",
       "})\n",
       "</script>\n",
       "</div>\n"
      ],
      "text/plain": [
       "   Number                        Type of Product - Treatment  \\\n",
       "1       1        TAK-888, antibodies from recovered COVID-19   \n",
       "3       2  Antibodies from mice, REGN3048-3051, against t...   \n",
       "4       3        Antibodies from recovered COVID-19 patients   \n",
       "5       4        Antibodies from recovered COVID-19 patients   \n",
       "6       5        Antibodies from recovered COVID-19 patients   \n",
       "..    ...                                                ...   \n",
       "0      72  nafamostat, approved in Japan to treat pancrea...   \n",
       "1      73  A number of synthesized nanoviricide drug cand...   \n",
       "2      74                                           losartan   \n",
       "3      75  Activase (alteplase), tissue plasminogen activ...   \n",
       "5       1                  Washed microbiota transplantation   \n",
       "\n",
       "   FDA-Approved Indications  \\\n",
       "1                       N/A   \n",
       "3                       N/A   \n",
       "4                       N/A   \n",
       "5                       N/A   \n",
       "6                       N/A   \n",
       "..                      ...   \n",
       "0                       NaN   \n",
       "1                       NaN   \n",
       "2                       NaN   \n",
       "3                       NaN   \n",
       "5                       NaN   \n",
       "\n",
       "                                 Developer/Researcher  \\\n",
       "1                                              Takeda   \n",
       "3                                           Regeneron   \n",
       "4                                           Celltrion   \n",
       "5                                              Kamada   \n",
       "6                   Vir Biotech/WuXi Biologics/Biogen   \n",
       "..                                                ...   \n",
       "0   University of Tokyo/ National Center for Globa...   \n",
       "1                                       NanoViricides   \n",
       "2                             University of Minnesota   \n",
       "3   Beth Israel Deaconess, the University of Color...   \n",
       "5   The Second Hospital of Nanjing Medical University   \n",
       "\n",
       "   Current Stage of Development  \\\n",
       "1                  Pre-clinical   \n",
       "3                  Pre-clinical   \n",
       "4                  Pre-clinical   \n",
       "5                  Pre-clinical   \n",
       "6                  Pre-clinical   \n",
       "..                          ...   \n",
       "0                  Pre-clinical   \n",
       "1                  Pre-clinical   \n",
       "2                      Clinical   \n",
       "3             Compassionate Use   \n",
       "5                      Clinical   \n",
       "\n",
       "                                      Funding Sources  \\\n",
       "1                                                 NaN   \n",
       "3   Biomedical Advanced Research and Development A...   \n",
       "4                                                 NaN   \n",
       "5                                                 NaN   \n",
       "6                                                 NaN   \n",
       "..                                                ...   \n",
       "0                                                 NaN   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "5                                                 NaN   \n",
       "\n",
       "                        Anticipated Next Steps Timing  \\\n",
       "1   To patients between September 2020 and Septemb...   \n",
       "3                             Start Phase 1 June 2020   \n",
       "4                        Start Phase 1 September 2020   \n",
       "5                                                 NaN   \n",
       "6                           Start Phase 1 ~ July 2020   \n",
       "..                                                ...   \n",
       "0                             Trial starts April 2020   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "5                    Primary trial ends April 2, 2020   \n",
       "\n",
       "                                              Sources  \\\n",
       "1                           PhRMA Wall Street Journal   \n",
       "3   Stat News MarketWatch Reuters Bloomberg News F...   \n",
       "4                                        Korea Herald   \n",
       "5                                     BioSpace AbbVie   \n",
       "6                               Stat News Vir Biotech   \n",
       "..                                                ...   \n",
       "0                                      Bloomberg News   \n",
       "1            Clinical Trials Arena NanoViricides Inc.   \n",
       "2                          ClinicalTrials.gov KARE TV   \n",
       "3                                            MIT News   \n",
       "5                                                 NaN   \n",
       "\n",
       "                FDA-Approved Indications (Treatments)  \\\n",
       "1                                                 NaN   \n",
       "3                                                 NaN   \n",
       "4                                                 NaN   \n",
       "5                                                 NaN   \n",
       "6                                                 NaN   \n",
       "..                                                ...   \n",
       "0                                                 N/A   \n",
       "1                                                 N/A   \n",
       "2   FDA-approved since 1995, approved to treat hyp...   \n",
       "3   FDA-approved since 1987, approved to treat str...   \n",
       "5                                             Unknown   \n",
       "\n",
       "   Clinical Trials Ongoing for Other Diseases Developer/ Researcher  \n",
       "1                                         NaN                   NaN  \n",
       "3                                         NaN                   NaN  \n",
       "4                                         NaN                   NaN  \n",
       "5                                         NaN                   NaN  \n",
       "6                                         NaN                   NaN  \n",
       "..                                        ...                   ...  \n",
       "0                                         NaN                   NaN  \n",
       "1                                         NaN                   NaN  \n",
       "2                                         NaN                   NaN  \n",
       "3                                         NaN                   NaN  \n",
       "5                                         NaN                   NaN  \n",
       "\n",
       "[76 rows x 11 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_all"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Citation\n",
    "\n",
    "Lucas, A. COVID-19 Vaccine Development Tracker. 27 Mar. 2020, covid-vaccine-tracker.com. DOI:10.5281/zenodo.3731761"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
